#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
CRP.3000518.AP009048.4153663_4154296.461	CRP.3000518.AP009048.4153663_4154296.461	1	0	539	428	CRP	633	633	99.53	CRP.l6.c30.ctg.1	1039	21.9	0	.	p	.	0	K29T	NONSYN	85	87	AAG	268	270	ACG	17;17;16	A;C;G	17;17;16	.	CRP is a global regulator that represses MdtEF multidrug efflux pump expression.;CRP
Chlamydophila_psittaci_16S.3003485.AB001778.1.0_1507.3258	Chlamydophila_psittaci_16S.3003485.AB001778.1.0_1507.3258	0	0	528	252	Chlamydophila_psittaci_16S	1507	116	92.24	Chlamydophila_psittaci_16S.l15.c4.ctg.1	126	20.5	0	.	n	.	0	A888G	SNP	888	888	A	5	5	G	3	G	3	.	Chlamydophila psittaci 16S rRNA mutation conferring resistance to spectinomycin
Chlamydophila_psittaci_16S.3003485.AB001778.1.0_1507.3258	Chlamydophila_psittaci_16S.3003485.AB001778.1.0_1507.3258	0	0	528	252	Chlamydophila_psittaci_16S	1507	116	92.24	Chlamydophila_psittaci_16S.l15.c4.ctg.1	126	20.5	0	.	n	.	0	C897G	SNP	897	897	C	14	14	G	9	G	9	.	Chlamydophila psittaci 16S rRNA mutation conferring resistance to spectinomycin
Chlamydophila_psittaci_16S.3003485.AB001778.1.0_1507.3258	Chlamydophila_psittaci_16S.3003485.AB001778.1.0_1507.3258	0	0	528	252	Chlamydophila_psittaci_16S	1507	116	92.24	Chlamydophila_psittaci_16S.l15.c4.ctg.1	126	20.5	0	.	n	.	0	T898C	SNP	898	898	T	15	15	C	9	C	9	.	Chlamydophila psittaci 16S rRNA mutation conferring resistance to spectinomycin
Chlamydophila_psittaci_16S.3003485.AB001778.1.0_1507.3258	Chlamydophila_psittaci_16S.3003485.AB001778.1.0_1507.3258	0	0	528	252	Chlamydophila_psittaci_16S	1507	116	92.24	Chlamydophila_psittaci_16S.l15.c4.ctg.1	126	20.5	0	.	n	.	0	G906T	SNP	906	906	G	23	23	T	15	T	15	.	Chlamydophila psittaci 16S rRNA mutation conferring resistance to spectinomycin
Chlamydophila_psittaci_16S.3003485.AB001778.1.0_1507.3258	Chlamydophila_psittaci_16S.3003485.AB001778.1.0_1507.3258	0	0	528	252	Chlamydophila_psittaci_16S	1507	116	92.24	Chlamydophila_psittaci_16S.l15.c4.ctg.1	126	20.5	0	.	n	.	0	G908A	SNP	908	908	G	25	25	A	16	A	16	.	Chlamydophila psittaci 16S rRNA mutation conferring resistance to spectinomycin
Chlamydophila_psittaci_16S.3003485.AB001778.1.0_1507.3258	Chlamydophila_psittaci_16S.3003485.AB001778.1.0_1507.3258	0	0	528	252	Chlamydophila_psittaci_16S	1507	116	92.24	Chlamydophila_psittaci_16S.l15.c4.ctg.1	126	20.5	0	.	n	.	0	A918T	SNP	918	918	A	35	35	T	19	T	19	.	Chlamydophila psittaci 16S rRNA mutation conferring resistance to spectinomycin
Chlamydophila_psittaci_16S.3003485.AB001778.1.0_1507.3258	Chlamydophila_psittaci_16S.3003485.AB001778.1.0_1507.3258	0	0	528	252	Chlamydophila_psittaci_16S	1507	116	92.24	Chlamydophila_psittaci_16S.l15.c4.ctg.1	126	20.5	0	.	n	.	0	A943G	SNP	943	943	A	60	60	G	39	G	39	.	Chlamydophila psittaci 16S rRNA mutation conferring resistance to spectinomycin
Chlamydophila_psittaci_16S.3003485.AB001778.1.0_1507.3258	Chlamydophila_psittaci_16S.3003485.AB001778.1.0_1507.3258	0	0	528	252	Chlamydophila_psittaci_16S	1507	116	92.24	Chlamydophila_psittaci_16S.l15.c4.ctg.1	126	20.5	0	.	n	.	0	G991T	SNP	991	991	G	108	108	T	23	T	23	.	Chlamydophila psittaci 16S rRNA mutation conferring resistance to spectinomycin
Escherichia_coli_EF_Tu.3003370.NC_000913.3.3470144_3471329.3532	Escherichia_coli_EF_Tu.3003370.NC_000913.3.3470144_3471329.3532	1	1	179	1728	Escherichia_coli_EF_Tu	1185	1176	99.57	Escherichia_coli_EF_Tu.l15.c17.ctg.1	1176	69.2	0	HET	.	.	.	T135C	.	135	135	T	134	134	T	49	T,C	31,17	.	Escherichia coli EF-Tu mutants conferring resistance to Enacyloxin IIa
Escherichia_coli_EF_Tu.3003370.NC_000913.3.3470144_3471329.3532	Escherichia_coli_EF_Tu.3003370.NC_000913.3.3470144_3471329.3532	1	1	179	1728	Escherichia_coli_EF_Tu	1185	1176	99.57	Escherichia_coli_EF_Tu.l15.c17.ctg.1	1176	69.2	0	HET	.	.	.	C216T	.	216	216	C	215	215	C	60	C,T	36,19	.	Escherichia coli EF-Tu mutants conferring resistance to Enacyloxin IIa
Escherichia_coli_EF_Tu.3003370.NC_000913.3.3470144_3471329.3532	Escherichia_coli_EF_Tu.3003370.NC_000913.3.3470144_3471329.3532	1	1	179	1728	Escherichia_coli_EF_Tu	1185	1176	99.57	Escherichia_coli_EF_Tu.l15.c17.ctg.1	1176	69.2	0	HET	.	.	.	C951A	.	951	951	C	950	950	C	67	C,A	38,29	.	Escherichia coli EF-Tu mutants conferring resistance to Enacyloxin IIa
Escherichia_coli_mutant.3003889.HG738867.2233288_2234647.3666	Escherichia_coli_mutant.3003889.HG738867.2233288_2234647.3666	1	1	539	648	Escherichia_coli_mutant_1	1359	1359	99.85	Escherichia_coli_mutant_1.l15.c30.ctg.1	1759	19.7	1	SNP	p	E448K	1	E448K	NONSYN	1342	1344	GAA	1539	1541	AAA	5;5;4	A;A;A	5;5;4	Escherichia_coli_mutant.3003889.HG738867.2233288_2234647.3666:1:1:E448K:.:Mutations to the active importer GlpT, which is involved with the uptake of many phosphorylated sugars, confer resistance to fosfomycin by reducing import of the drug into the bacteria.	Escherichia coli mutant GlpT conferring resistance to fosfomycin
Escherichia_coli_mutant.3003890.HG738867.2934266_2935658.3667	Escherichia_coli_mutant.3003890.HG738867.2934266_2935658.3667	1	1	27	822	Escherichia_coli_mutant	1392	1392	99.43	Escherichia_coli_mutant.l15.c4.ctg.1	1677	26.2	1	SNP	p	E350Q	0	.	.	1048	1050	GAA	1209	1211	GAA	28;27;28	G;A;A	28;27;28	Escherichia_coli_mutant.3003890.HG738867.2934266_2935658.3667:1:1:E350Q:.:Mutations to the active importer UhpT, which is involved with the uptake of many phosphorylated sugars, confer resistance to fosfomycin by reducing import of the drug into the bacteria.	Escherichia coli mutant UhpT conferring resistance to fosfomycin
H_NS.3000676.NC_002695.1737553_1737967.218	H_NS.3000676.NC_002695.1737553_1737967.218	1	0	27	138	H_NS	414	414	99.03	H_NS.l6.c30.ctg.1	759	9.7	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	H-NS;H-NS is a histone-like protein involved in global gene regulation in Gram-negative bacteria. It is a repressor of the membrane fusion protein genes acrE, mdtE, and emrK as well as nearby genes of many RND-type multidrug exporters.
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	512	2436	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c30.ctg.2	784	82.6	0	.	n	.	0	A1136G	SNP	1136	1136	A	96	96	G	153	G	153	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	512	2436	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c30.ctg.2	784	82.6	0	.	n	.	0	T1138C	SNP	1138	1138	T	98	98	C	147	C	147	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	512	2436	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c30.ctg.2	784	82.6	0	.	n	.	0	T1142C	SNP	1142	1142	T	102	102	C	140	C	140	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	512	2436	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c30.ctg.2	784	82.6	0	.	n	.	0	C1170T	SNP	1170	1170	C	130	130	T	129	T,C	128,1	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	512	2436	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c30.ctg.2	784	82.6	0	.	n	.	0	T1220C	SNP	1220	1220	T	180	180	C	133	C	132	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	512	2436	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c30.ctg.2	784	82.6	0	.	n	.	0	T1245C	SNP	1245	1245	T	205	205	C	108	C	107	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	512	2436	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c30.ctg.2	784	82.6	0	.	n	.	0	G1253A	SNP	1253	1253	G	213	213	A	109	A	109	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	512	2436	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c30.ctg.2	784	82.6	0	.	n	.	0	G1256A	SNP	1256	1256	G	216	216	A	107	A	107	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	512	2436	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c30.ctg.2	784	82.6	0	.	n	.	0	C1258A	SNP	1258	1258	C	218	218	A	112	A	111	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	512	2436	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c30.ctg.2	784	82.6	0	.	n	.	0	G1266T	SNP	1266	1266	G	226	226	T	102	T	102	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	512	2436	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c30.ctg.2	784	82.6	0	.	n	.	0	T1267C	SNP	1267	1267	T	227	227	C	102	C	102	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	512	2436	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c30.ctg.2	784	82.6	0	.	n	.	0	T1275C	SNP	1275	1275	T	235	235	C	100	C,T	99,1	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	512	2436	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c30.ctg.2	784	82.6	0	.	n	.	0	G1276A	SNP	1276	1276	G	236	236	A	99	A	99	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	512	2436	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c30.ctg.2	784	82.6	0	.	n	.	0	A1281G	SNP	1281	1281	A	241	241	G	89	G	89	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	512	2436	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c30.ctg.2	784	82.6	0	.	n	.	0	T1283C	SNP	1283	1283	T	243	243	C	90	C	90	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	512	2436	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c30.ctg.2	784	82.6	0	.	n	.	0	G1288T	SNP	1288	1288	G	248	248	T	101	T	101	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	512	2436	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c30.ctg.2	784	82.6	0	.	n	.	0	A1296G	SNP	1296	1296	A	256	256	G	130	G	130	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	512	2436	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c30.ctg.2	784	82.6	0	.	n	.	0	T1299G	SNP	1299	1299	T	259	259	G	131	G,T	130,1	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	512	2436	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c30.ctg.2	784	82.6	0	.	n	.	0	A1300T	SNP	1300	1300	A	260	260	T	132	T	132	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	512	2436	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c30.ctg.2	784	82.6	0	.	n	.	0	C1356T	SNP	1356	1356	C	316	316	T	121	T	121	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	512	2436	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c30.ctg.2	784	82.6	0	.	n	.	0	A1358G	SNP	1358	1358	A	318	318	G	114	G	114	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	512	2436	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c30.ctg.2	784	82.6	0	.	n	.	0	T1368C	SNP	1368	1368	T	328	328	C	95	C	95	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	512	2436	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c30.ctg.2	784	82.6	0	.	n	.	0	G1370A	SNP	1370	1370	G	330	330	A	91	A	91	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	512	2436	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c30.ctg.2	784	82.6	0	.	n	.	0	C1406.	DEL	1406	1406	C	365	365	C	53	C	53	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	512	2436	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c30.ctg.2	784	82.6	0	.	n	.	0	.1409C	INS	1409	1409	T	369	369	C	48	C	47	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	512	2436	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c30.ctg.2	784	82.6	0	.	n	.	0	C1431A	SNP	1431	1431	C	391	391	A	2	A	2	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	512	2436	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c30.ctg.2	784	82.6	0	.	n	.	0	C1432A	SNP	1432	1432	C	392	392	A	2	A	2	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	512	2436	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c30.ctg.2	784	82.6	0	.	n	.	0	A1441G	SNP	1441	1441	A	401	401	G	3	G	3	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	512	2436	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c30.ctg.2	784	82.6	0	.	n	.	0	T1464C	SNP	1464	1464	T	424	424	C	18	C	18	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	512	2436	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c30.ctg.2	784	82.6	0	.	n	.	0	G1473T	SNP	1473	1473	G	433	433	T	69	T	69	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	512	2436	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c30.ctg.2	784	82.6	0	.	n	.	0	A1475G	SNP	1475	1475	A	435	435	G	74	G	74	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	512	2436	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c30.ctg.2	784	82.6	0	.	n	.	0	A1548T	SNP	1548	1548	A	508	508	T	44	T	44	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	512	2436	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c30.ctg.2	784	82.6	1	SNP	n	C1194G	0	.	.	1194	1194	C	154	154	C	127	C	127	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252:0:0:C1194G:.:Point mutations in the helix 34 region of 16S rRNA of Pasteurella multocida can confer resistance to spectinomycin	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	512	2436	Pasteurella_multocida_16S	1551	96	94.79	Pasteurella_multocida_16S.l15.c30.ctg.3	97	90.4	0	.	n	.	0	A303G	SNP	303	303	A	6	6	G	44	G	44	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	512	2436	Pasteurella_multocida_16S	1551	96	94.79	Pasteurella_multocida_16S.l15.c30.ctg.3	97	90.4	0	.	n	.	0	G375A	SNP	375	375	G	78	78	A	52	A	52	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	512	2436	Pasteurella_multocida_16S	1551	96	94.79	Pasteurella_multocida_16S.l15.c30.ctg.3	97	90.4	0	.	n	.	0	G383C	SNP	383	383	G	86	86	C	27	C	27	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	512	2436	Pasteurella_multocida_16S	1551	96	94.79	Pasteurella_multocida_16S.l15.c30.ctg.3	97	90.4	0	.	n	.	0	G385C	SNP	385	385	G	88	88	C	18	C	18	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	512	2436	Pasteurella_multocida_16S	1551	96	94.79	Pasteurella_multocida_16S.l15.c30.ctg.3	97	90.4	0	.	n	.	0	C388G	SNP	388	388	C	91	91	G	10	G	10	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
PmrB.3003583.NC_007779.4336858_4337950.2119	PmrB.3003583.NC_007779.4336858_4337950.2119	1	0	539	698	PmrB_1	1092	1092	99.08	PmrB_1.l15.c4.ctg.1	1462	25.6	0	.	p	.	0	H2R	NONSYN	4	6	CAT	190	192	CGT	21;23;23	C;G;T	21;23;23	.	PmrB;Histidine protein kinase sensor Lipid A modification gene; part of a two-component system involved in polymyxin resistance that senses high extracellular Fe(2+)
PmrB.3003583.NC_007779.4336858_4337950.2119	PmrB.3003583.NC_007779.4336858_4337950.2119	1	0	539	698	PmrB_1	1092	1092	99.08	PmrB_1.l15.c4.ctg.1	1462	25.6	0	.	p	.	0	V30I	NONSYN	88	90	GTC	274	276	ATC	22;21;21	A;T;C	22;21;21	.	PmrB;Histidine protein kinase sensor Lipid A modification gene; part of a two-component system involved in polymyxin resistance that senses high extracellular Fe(2+)
PmrB.3003583.NC_007779.4336858_4337950.2119	PmrB.3003583.NC_007779.4336858_4337950.2119	1	0	539	698	PmrB_1	1092	1092	99.08	PmrB_1.l15.c4.ctg.1	1462	25.6	0	.	p	.	0	D283G	NONSYN	847	849	GAC	1033	1035	GGC	16;16;16	G;G;C	16;16;16	.	PmrB;Histidine protein kinase sensor Lipid A modification gene; part of a two-component system involved in polymyxin resistance that senses high extracellular Fe(2+)
PmrC.3003576.AP009048.4338624_4340268.2117	PmrC.3003576.AP009048.4338624_4340268.2117	1	0	539	950	PmrC	1644	1644	99.15	PmrC.l15.c4.ctg.1	2024	25.1	0	.	p	.	0	R8S	NONSYN	22	24	AGA	181	183	AGC	4;4;4	A;G;C	4;4;4	.	PmrC;PmrC mediates the modification of Lipid A by the addition of 4-amino-4-deoxy-L-arabinose (L-Ara4N) and phosphoethanolamine, resulting in a less negative cell membrane and decreased binding of polymyxin B.
PmrC.3003576.AP009048.4338624_4340268.2117	PmrC.3003576.AP009048.4338624_4340268.2117	1	0	539	950	PmrC	1644	1644	99.15	PmrC.l15.c4.ctg.1	2024	25.1	0	.	p	.	0	I142L	NONSYN	424	426	ATA	583	585	CTA	17;17;17	C;T;A	17;17;17	.	PmrC;PmrC mediates the modification of Lipid A by the addition of 4-amino-4-deoxy-L-arabinose (L-Ara4N) and phosphoethanolamine, resulting in a less negative cell membrane and decreased binding of polymyxin B.
PmrC.3003576.AP009048.4338624_4340268.2117	PmrC.3003576.AP009048.4338624_4340268.2117	1	0	539	950	PmrC	1644	1644	99.15	PmrC.l15.c4.ctg.1	2024	25.1	0	.	p	.	0	R315Q	NONSYN	943	945	CGA	1102	1104	CAA	43;46;46	C;A;A	43;46;46	.	PmrC;PmrC mediates the modification of Lipid A by the addition of 4-amino-4-deoxy-L-arabinose (L-Ara4N) and phosphoethanolamine, resulting in a less negative cell membrane and decreased binding of polymyxin B.
PmrC.3003576.AP009048.4338624_4340268.2117	PmrC.3003576.AP009048.4338624_4340268.2117	1	0	539	950	PmrC	1644	1644	99.15	PmrC.l15.c4.ctg.1	2024	25.1	0	.	p	.	0	D348G	NONSYN	1042	1044	GAT	1201	1203	GGT	50;47;47	G;G;T	50;47;47	.	PmrC;PmrC mediates the modification of Lipid A by the addition of 4-amino-4-deoxy-L-arabinose (L-Ara4N) and phosphoethanolamine, resulting in a less negative cell membrane and decreased binding of polymyxin B.
PmrC.3003576.AP009048.4338624_4340268.2117	PmrC.3003576.AP009048.4338624_4340268.2117	1	0	539	950	PmrC	1644	1644	99.15	PmrC.l15.c4.ctg.1	2024	25.1	0	.	p	.	0	I538V	NONSYN	1612	1614	ATT	1771	1773	GTT	15;15;14	G;T;T	15;15;14	.	PmrC;PmrC mediates the modification of Lipid A by the addition of 4-amino-4-deoxy-L-arabinose (L-Ara4N) and phosphoethanolamine, resulting in a less negative cell membrane and decreased binding of polymyxin B.
PmrE.3003577.U00096.2098446_2099613.2116	PmrE.3003577.U00096.2098446_2099613.2116	1	0	539	342	PmrE	1167	1167	96.83	PmrE.l15.c4.ctg.1	1375	12.8	0	.	p	.	0	A125E	NONSYN	373	375	GCA	574	576	GAA	11;10;9	G;A;A	11;10;9	.	PmrE;PmrE is required for the synthesis and transfer of 4-amino-4-deoxy-L-arabinose (Ara4N) to Lipid A, which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin
PmrE.3003577.U00096.2098446_2099613.2116	PmrE.3003577.U00096.2098446_2099613.2116	1	0	539	342	PmrE	1167	1167	96.83	PmrE.l15.c4.ctg.1	1375	12.8	0	.	p	.	0	M185T	NONSYN	553	555	ATG	754	756	ACC	10;10;9	A;C;C	10;10;9	.	PmrE;PmrE is required for the synthesis and transfer of 4-amino-4-deoxy-L-arabinose (Ara4N) to Lipid A, which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin
PmrE.3003577.U00096.2098446_2099613.2116	PmrE.3003577.U00096.2098446_2099613.2116	1	0	539	342	PmrE	1167	1167	96.83	PmrE.l15.c4.ctg.1	1375	12.8	0	.	p	.	0	S225T	NONSYN	673	675	TCC	874	876	ACT	9;9;9	A;C;T	9;9;9	.	PmrE;PmrE is required for the synthesis and transfer of 4-amino-4-deoxy-L-arabinose (Ara4N) to Lipid A, which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin
PmrE.3003577.U00096.2098446_2099613.2116	PmrE.3003577.U00096.2098446_2099613.2116	1	0	539	342	PmrE	1167	1167	96.83	PmrE.l15.c4.ctg.1	1375	12.8	0	.	p	.	0	T355I	NONSYN	1063	1065	ACC	1264	1266	ATC	6;6;7	A;T;C	6;6;7	.	PmrE;PmrE is required for the synthesis and transfer of 4-amino-4-deoxy-L-arabinose (Ara4N) to Lipid A, which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin
PmrF.3003578.U00096.2367070_2368039.2115	PmrF.3003578.U00096.2367070_2368039.2115	1	0	27	420	PmrF	969	969	99.38	PmrF.l15.c4.ctg.1	1356	16.5	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	PmrF is required for the synthesis and transfer of 4-amino-4-deoxy-L-arabinose (Ara4N) to Lipid A, which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin;PmrF
TEM_178.3001043.X97254.153_1011.1492	TEM_178.3001043.X97254.153_1011.1492	1	0	512	34	TEM_1+	858	157	98.73	TEM_1+.l6.c30.ctg.1	157	2.1	0	.	p	.	0	V82I	NONSYN	244	246	GTT	99	101	ATT	2;2;2	A;T;T	2;2;2	.	TEM-178 is an inhibitor-resistant, extended-spectrum beta-lactamase.;TEM-178
TEM_178.3001043.X97254.153_1011.1492	TEM_178.3001043.X97254.153_1011.1492	1	0	512	34	TEM_1+	858	145	97.97	TEM_1+.l6.c30.ctg.2	148	1.9	0	.	p	.	0	M209_A210insE	INS	625	625	A	68	68	A	2	A	2	.	TEM-178 is an inhibitor-resistant, extended-spectrum beta-lactamase.;TEM-178
aada1.manually_added_NC_007384_WP_001206315.1_4110458_4111246	aada1.manually_added_NC_007384_WP_001206315.1_4110458_4111246	1	0	27	524	aad-	789	789	100.0	aad-.l15.c17.ctg.1	1174	23.6	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Original ref seq: NC_007384.1 Shigella sonnei Ss046, complete genome
acrB.3000216.DQ679966.1515_4662.624	acrB.3000216.DQ679966.1515_4662.624	1	0	16	66	acrB	3147	141	91.49	acrB.l6.c4.ctg.2	147	9.9	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Protein subunit of AcrA-AcrB-TolC multidrug efflux complex. AcrB functions as a herterotrimer which forms the inner membrane component and is primarily responsible for substrate recognition and energy transduction by acting as a drug/proton antiporter.;acrB
acrD.3000491.NC_007779.2586250_2589364.664	acrD.3000491.NC_007779.2586250_2589364.664	1	0	539	1622	acrD	3114	3114	99.07	acrD.l15.c30.ctg.1	3500	24.8	0	.	p	.	0	T85I	NONSYN	253	255	ACC	468	470	ATC	20;20;20	A;T;C	20;20;20	.	acrD;AcrD is an aminoglycoside efflux pump expressed in E. coli. Its expression can be induced by indole, and is regulated by baeRS and cpxAR.
acrD.3000491.NC_007779.2586250_2589364.664	acrD.3000491.NC_007779.2586250_2589364.664	1	0	539	1622	acrD	3114	3114	99.07	acrD.l15.c30.ctg.1	3500	24.8	0	.	p	.	0	V416I	NONSYN	1246	1248	GTC	1461	1463	ATC	16;16;17	A;T;C	16;16;17	.	acrD;AcrD is an aminoglycoside efflux pump expressed in E. coli. Its expression can be induced by indole, and is regulated by baeRS and cpxAR.
acrD.3000491.NC_007779.2586250_2589364.664	acrD.3000491.NC_007779.2586250_2589364.664	1	0	539	1622	acrD	3114	3114	99.07	acrD.l15.c30.ctg.1	3500	24.8	0	.	p	.	0	Q656K	NONSYN	1966	1968	CAA	2181	2183	AAG	24;25;26	A;A;G	24;25;26	.	acrD;AcrD is an aminoglycoside efflux pump expressed in E. coli. Its expression can be induced by indole, and is regulated by baeRS and cpxAR.
acrE.3000499.U00096.3413863_3415021.333	acrE.3000499.U00096.3413863_3415021.333	1	0	539	646	acrE	1158	1158	98.79	acrE.l15.c17.ctg.1	1437	23.8	0	.	p	.	0	A22V	NONSYN	64	66	GCC	149	151	GTC	7;8;7	G;T;C	7;8;7	.	AcrE is a membrane fusion protein, similar to AcrA.;acrE
acrE.3000499.U00096.3413863_3415021.333	acrE.3000499.U00096.3413863_3415021.333	1	0	539	646	acrE	1158	1158	98.79	acrE.l15.c17.ctg.1	1437	23.8	0	.	p	.	0	S269C	NONSYN	805	807	AGC	890	892	TGC	26;27;27	T;G;C	26;27;27	.	AcrE is a membrane fusion protein, similar to AcrA.;acrE
acrF.3000502.U00096.3415032_3418137.700	acrF.3000502.U00096.3415032_3418137.700	1	0	656	1556	acrF	3105	2598	98.04	acrF.l15.c17.ctg.1	2805	28.9	0	.	p	.	0	S46trunc	TRUNC	136	136	T	181	181	T	19	T	19	.	AcrF is a inner membrane transporter, similar to AcrB.;acrF
acrF.3000502.U00096.3415032_3418137.700	acrF.3000502.U00096.3415032_3418137.700	1	0	656	1556	acrF	3105	2598	98.04	acrF.l15.c17.ctg.1	2805	28.9	0	.	p	.	0	G148D	NONSYN	442	444	GGC	487	489	GAC	27;26;24	G;A;C	26;26;24	.	AcrF is a inner membrane transporter, similar to AcrB.;acrF
acrF.3000502.U00096.3415032_3418137.700	acrF.3000502.U00096.3415032_3418137.700	1	0	656	1556	acrF	3105	2598	98.04	acrF.l15.c17.ctg.1	2805	28.9	0	.	p	.	0	F240L	NONSYN	718	720	TTT	763	765	TTA	9;10;10	T;T;A	9;10;10	.	AcrF is a inner membrane transporter, similar to AcrB.;acrF
acrF.3000502.U00096.3415032_3418137.700	acrF.3000502.U00096.3415032_3418137.700	1	0	656	1556	acrF	3105	2598	98.04	acrF.l15.c17.ctg.1	2805	28.9	0	.	p	.	0	D301N	NONSYN	901	903	GAT	946	948	AAT	23;23;23	A;A;T	22;22;22	.	AcrF is a inner membrane transporter, similar to AcrB.;acrF
acrF.3000502.U00096.3415032_3418137.700	acrF.3000502.U00096.3415032_3418137.700	1	0	656	1556	acrF	3105	2598	98.04	acrF.l15.c17.ctg.1	2805	28.9	0	.	p	.	0	L563fs	FSHIFT	1687	1687	T	1733	1733	T	29	T	29	.	AcrF is a inner membrane transporter, similar to AcrB.;acrF
acrF.3000502.U00096.3415032_3418137.700	acrF.3000502.U00096.3415032_3418137.700	1	0	656	1556	acrF	3105	2598	98.04	acrF.l15.c17.ctg.1	2805	28.9	0	HET	.	.	.	G186A	.	186	186	G	231	231	G	43	G,A	35,8	.	AcrF is a inner membrane transporter, similar to AcrB.;acrF
acrR.3003807.NC_000913.3.485760_486408.3575	acrR.3003807.NC_000913.3.485760_486408.3575	1	1	27	336	acrR_2	648	648	99.54	acrR_2.l6.c30.ctg.1	1044	17.3	1	SNP	p	R45C	0	.	.	133	135	CGC	328	330	CGC	26;26;27	C;G;C	26;26;27	acrR.3003807.NC_000913.3.485760_486408.3575:1:1:R45C:.:AcrR is a repressor of the AcrAB-TolC multidrug efflux complex. AcrR mutations result in high level antibiotic resistance. The mutations associated with this model are specific to E. coli.	Escherichia coli acrR mutants resulting in antibiotic resistance
acrS.3000656.U00096.3412802_3413465.551	acrS.3000656.U00096.3412802_3413465.551	1	0	539	330	acrS	663	663	98.64	acrS.l15.c4.ctg.1	807	20.8	0	.	p	.	0	L34F	NONSYN	100	102	CTC	168	170	TTC	27;27;27	T;T;C	27;26;27	.	acrS;AcrS is a repressor of the AcrAB efflux complex and is associated with the expression of AcrEF. AcrS is believed to regulate a switch between AcrAB and AcrEF efflux.
acrS.3000656.U00096.3412802_3413465.551	acrS.3000656.U00096.3412802_3413465.551	1	0	539	330	acrS	663	663	98.64	acrS.l15.c4.ctg.1	807	20.8	0	.	p	.	0	E122G	NONSYN	364	366	GAG	432	434	GGG	21;21;26	G;G;G	21;21;26	.	acrS;AcrS is a repressor of the AcrAB efflux complex and is associated with the expression of AcrEF. AcrS is believed to regulate a switch between AcrAB and AcrEF efflux.
adiY.3003828.NC_000913.3.4337167_4337929.3591	adiY.3003828.NC_000913.3.4337167_4337929.3591	1	0	539	354	adiY	762	762	99.61	adiY.l15.c30.ctg.1	1142	16.5	0	.	p	.	0	V136L	NONSYN	406	408	GTT	603	605	CTT	22;22;22	C;T;T	22;22;22	.	adiY;adiY is a DNA-binding transcriptional activator of the adi system. Implicated in arginine-dependent acid resistance in Escherichia coli.
alaS.3003830.NC_000913.3.2819380_2822011.3592	alaS.3003830.NC_000913.3.2819380_2822011.3592	1	0	539	1754	alaS	2631	2631	98.86	alaS.l15.c4.ctg.1	3036	31.1	0	.	p	.	0	T618A	NONSYN	1852	1854	ACA	2029	2031	GCA	42;45;46	G;C;A	42;45;46	.	aminocoumarin resistant alaS;alanyl-tRNA synthetase conferring resistance to novobiocin in Escherichia coli
alaS.3003830.NC_000913.3.2819380_2822011.3592	alaS.3003830.NC_000913.3.2819380_2822011.3592	1	0	539	1754	alaS	2631	2631	98.86	alaS.l15.c4.ctg.1	3036	31.1	0	.	p	.	0	A705T	NONSYN	2113	2115	GCC	2290	2292	ACC	31;32;31	A;C;C	30;32;30	.	aminocoumarin resistant alaS;alanyl-tRNA synthetase conferring resistance to novobiocin in Escherichia coli
alaS.3003830.NC_000913.3.2819380_2822011.3592	alaS.3003830.NC_000913.3.2819380_2822011.3592	1	0	539	1754	alaS	2631	2631	98.86	alaS.l15.c4.ctg.1	3036	31.1	0	.	p	.	0	V808A	NONSYN	2422	2424	GTC	2599	2601	GCC	27;26;27	G;C;C	26;26;27	.	aminocoumarin resistant alaS;alanyl-tRNA synthetase conferring resistance to novobiocin in Escherichia coli
arnA.3002985.U00096.2368038_2370021.355	arnA.3002985.U00096.2368038_2370021.355	1	0	539	828	arnA_1	1983	1983	98.29	arnA_1.l6.c30.ctg.1	2269	19.4	0	.	p	.	0	G37A	NONSYN	109	111	GGT	157	159	GCT	5;5;5	G;C;T	5;5;5	.	arnA;arnA modifies lipid A with 4-amino-4-deoxy-L-arabinose (Ara4N) which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin. arnA is found in E. coli and P. aeruginosa.
arnA.3002985.U00096.2368038_2370021.355	arnA.3002985.U00096.2368038_2370021.355	1	0	539	828	arnA_1	1983	1983	98.29	arnA_1.l6.c30.ctg.1	2269	19.4	0	.	p	.	0	D77E	NONSYN	229	231	GAT	277	279	GAG	5;5;5	G;A;G	5;5;5	.	arnA;arnA modifies lipid A with 4-amino-4-deoxy-L-arabinose (Ara4N) which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin. arnA is found in E. coli and P. aeruginosa.
arnA.3002985.U00096.2368038_2370021.355	arnA.3002985.U00096.2368038_2370021.355	1	0	539	828	arnA_1	1983	1983	98.29	arnA_1.l6.c30.ctg.1	2269	19.4	0	.	p	.	0	Y89C	NONSYN	265	267	TAC	313	315	TGC	4;4;6	T;G;C	4;4;6	.	arnA;arnA modifies lipid A with 4-amino-4-deoxy-L-arabinose (Ara4N) which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin. arnA is found in E. coli and P. aeruginosa.
arnA.3002985.U00096.2368038_2370021.355	arnA.3002985.U00096.2368038_2370021.355	1	0	539	828	arnA_1	1983	1983	98.29	arnA_1.l6.c30.ctg.1	2269	19.4	0	.	p	.	0	I150V	NONSYN	448	450	ATT	496	498	GTT	14;15;15	G;T;T	14;15;15	.	arnA;arnA modifies lipid A with 4-amino-4-deoxy-L-arabinose (Ara4N) which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin. arnA is found in E. coli and P. aeruginosa.
arnA.3002985.U00096.2368038_2370021.355	arnA.3002985.U00096.2368038_2370021.355	1	0	539	828	arnA_1	1983	1983	98.29	arnA_1.l6.c30.ctg.1	2269	19.4	0	.	p	.	0	R200H	NONSYN	598	600	CGC	646	648	CAC	21;20;20	C;A;C	21;20;20	.	arnA;arnA modifies lipid A with 4-amino-4-deoxy-L-arabinose (Ara4N) which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin. arnA is found in E. coli and P. aeruginosa.
arnA.3002985.U00096.2368038_2370021.355	arnA.3002985.U00096.2368038_2370021.355	1	0	539	828	arnA_1	1983	1983	98.29	arnA_1.l6.c30.ctg.1	2269	19.4	0	.	p	.	0	T295M	NONSYN	883	885	ACG	931	933	ATG	45;45;44	A;T,G;G	44;42,1;43	.	arnA;arnA modifies lipid A with 4-amino-4-deoxy-L-arabinose (Ara4N) which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin. arnA is found in E. coli and P. aeruginosa.
arnA.3002985.U00096.2368038_2370021.355	arnA.3002985.U00096.2368038_2370021.355	1	0	539	828	arnA_1	1983	1983	98.29	arnA_1.l6.c30.ctg.1	2269	19.4	0	.	p	.	0	H627R	NONSYN	1879	1881	CAC	1927	1929	CGC	12;11;11	C;G;C	12;11;11	.	arnA;arnA modifies lipid A with 4-amino-4-deoxy-L-arabinose (Ara4N) which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin. arnA is found in E. coli and P. aeruginosa.
bacA.3002986.U00096.3203309_3204131.36	bacA.3002986.U00096.3203309_3204131.36	1	0	539	366	bacA	822	822	98.54	bacA.l6.c30.ctg.1	1164	16.8	0	.	p	.	0	S221T	NONSYN	661	663	AGC	850	852	ACC	19;18;14	A;C;C	19;18;14	.	bacA is a gene that recycles undecaprenyl pyrophosphate during cell wall biosynthesis which confers resistance to bacitracin;bacA
bacA.3002986.U00096.3203309_3204131.36	bacA.3002986.U00096.3203309_3204131.36	1	0	539	366	bacA	822	822	98.54	bacA.l6.c30.ctg.1	1164	16.8	0	.	p	.	0	P225S	NONSYN	673	675	CCG	862	864	TCG	17;18;17	T;C;G	17;18;17	.	bacA is a gene that recycles undecaprenyl pyrophosphate during cell wall biosynthesis which confers resistance to bacitracin;bacA
baeR.3000828.NC_007779.2166412_2167135.676	baeR.3000828.NC_007779.2166412_2167135.676	1	0	513	354	baeR	723	545	97.61	baeR.l6.c30.ctg.1	757	20.8	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	baeR;BaeR is a response regulator that promotes the expression of MdtABC and AcrD efflux complexes.
baeR.3000828.NC_007779.2166412_2167135.676	baeR.3000828.NC_007779.2166412_2167135.676	1	0	513	354	baeR	723	177	97.74	baeR.l6.c30.ctg.2	287	10.3	0	.	p	.	0	N187D	NONSYN	559	561	AAT	13	15	GAT	16;17;17	G,A;A;T	0,10;10;11	.	baeR;BaeR is a response regulator that promotes the expression of MdtABC and AcrD efflux complexes.
baeS.3000829.AP009048.2165012_2166416.608	baeS.3000829.AP009048.2165012_2166416.608	1	0	539	634	baeS	1404	1404	98.86	baeS.l15.c30.ctg.1	1649	20.0	0	.	p	.	0	Q376K	NONSYN	1126	1128	CAA	1365	1367	AAA	3;3;3	A;A;A	3;3;3	.	baeS;BaeS is a sensor kinase in the BaeSR regulatory system. While it phosphorylates BaeR to increase its activity, BaeS is not necessary for overexpressed BaeR to confer resistance.
baeS.3000829.AP009048.2165012_2166416.608	baeS.3000829.AP009048.2165012_2166416.608	1	0	539	634	baeS	1404	1404	98.86	baeS.l15.c30.ctg.1	1649	20.0	0	.	p	.	0	G380E	NONSYN	1138	1140	GGG	1377	1379	GAG	5;6;6	G;A;G	5;6;6	.	baeS;BaeS is a sensor kinase in the BaeSR regulatory system. While it phosphorylates BaeR to increase its activity, BaeS is not necessary for overexpressed BaeR to confer resistance.
baeS.3000829.AP009048.2165012_2166416.608	baeS.3000829.AP009048.2165012_2166416.608	1	0	539	634	baeS	1404	1404	98.86	baeS.l15.c30.ctg.1	1649	20.0	0	.	p	.	0	R382H	NONSYN	1144	1146	CGC	1383	1385	CAC	6;6;7	C;A;C	6;6;7	.	baeS;BaeS is a sensor kinase in the BaeSR regulatory system. While it phosphorylates BaeR to increase its activity, BaeS is not necessary for overexpressed BaeR to confer resistance.
baeS.3000829.AP009048.2165012_2166416.608	baeS.3000829.AP009048.2165012_2166416.608	1	0	539	634	baeS	1404	1404	98.86	baeS.l15.c30.ctg.1	1649	20.0	0	.	p	.	0	D400E	NONSYN	1198	1200	GAT	1437	1439	GAG	18;18;17	G;A;G	18;18;17	.	baeS;BaeS is a sensor kinase in the BaeSR regulatory system. While it phosphorylates BaeR to increase its activity, BaeS is not necessary for overexpressed BaeR to confer resistance.
cpxA.3000830.NC_002695.4903561_4904935.605	cpxA.3000830.NC_002695.4903561_4904935.605	1	0	27	842	cpxA	1374	1374	98.91	cpxA.l15.c4.ctg.1	1632	27.3	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	CpxA is a membrane-localized sensor kinase that is activated by envelope stress. It starts a kinase cascade that activates CpxR, which promotes efflux complex expression.;cpxA
cpxR.3000831.NC_002695.4904931_4905630.142	cpxR.3000831.NC_002695.4904931_4905630.142	1	0	27	534	cpxR	699	699	99.43	cpxR.l15.c4.ctg.1	1087	26.2	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	cpxR;CpxR is a regulator that promotes acrD expression when phosphorylated by a cascade involving CpxA, a sensor kinase.
cysB.3003840.NC_000913.3.1333854_1334829.3604	cysB.3003840.NC_000913.3.1333854_1334829.3604	1	0	539	470	cysB	975	975	99.28	cysB.l15.c4.ctg.1	1391	18.2	0	.	p	.	0	A146T	NONSYN	436	438	GCT	668	670	ACT	27;27;29	A;C;T	27;27;29	.	Positive regulator of gene expression in the cysteine regulon. cysB mutants confer resistance to novobiocin, an aminocoumarin antibiotic, in Escherichia coli.;aminocoumarin resistant cysB
dfrA1.3002854.NC_010410.3676915_3677389.140	dfrA1.3002854.NC_010410.3676915_3677389.140	1	0	27	292	dfrA1_1	474	474	100.0	dfrA1_1.l6.c4.ctg.1	961	16.3	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	dfrA1 is an integron-encoded dihydrofolate reductase found in Escherichia coli;dfrA1
emrA.3000027.AP009048.2810082_2811255.411	emrA.3000027.AP009048.2810082_2811255.411	1	0	539	672	emrA	1173	1173	98.29	emrA.l6.c30.ctg.1	1573	23.0	0	.	p	.	0	I219V	NONSYN	655	657	ATC	860	862	GTC	34;34;34	G;T;C	32;34;33	.	emrA;EmrA is a membrane fusion protein, providing an efflux pathway with EmrB and TolC between the inner and outer membranes of E. coli, a Gram-negative bacterium.
emrB.3000074.U00096.2812615_2814154.20	emrB.3000074.U00096.2812615_2814154.20	1	0	539	1032	emrB	1539	1539	99.74	emrB.l15.c30.ctg.1	1935	28.5	0	.	p	.	0	E197K	NONSYN	589	591	GAA	810	812	AAA	26;26;26	A;A;A	26;26;26	.	emrB;emrB is a translocase in the emrB -TolC efflux protein in E. coli. It recognizes substrates including carbonyl cyanide m-chlorophenylhydrazone (CCCP), nalidixic acid, and thioloactomycin.
emrD.3000309.GG749185.1.116812_118003.3622	emrD.3000309.GG749185.1.116812_118003.3622	1	0	539	682	emrD	1191	1191	98.4	emrD.l6.c30.ctg.1	1406	24.8	0	.	p	.	0	G209S	NONSYN	625	627	GGC	762	764	AGC	24;24;25	A;G;C	24;23;25	.	EmrD is a multidrug transporter from the Major Facilitator Superfamily (MFS) primarily found in Escherichia coli. EmrD couples efflux of amphipathic compounds with proton import across the plasma membrane.;emrD
emrE.3000264.NC_007779.567537_567870.260	emrE.3000264.NC_007779.567537_567870.260	1	0	16	18	emrE_1	333	93	96.77	emrE_1.l15.c4.ctg.2	93	4.6	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	EmrE is a small multidrug transporter that functions as a homodimer and that couples the efflux of small polyaromatic cations from the cell with the import of protons down an electrochemical gradient. EmrE is found in E. coli and P. aeruginosa.;emrE
emrK.3000206.D78168.536_1592.173	emrK.3000206.D78168.536_1592.173	1	0	539	390	emrK	1056	1056	98.2	emrK.l15.c30.ctg.1	1465	14.2	0	.	p	.	0	K176R	NONSYN	526	528	AAG	720	722	AGG	12;12;12	A;G;G	12;12;12	.	emrK;emrK is a membrane fusion protein that is a homolog of EmrA. Together with the inner membrane transporter EmrY and the outer membrane channel TolC, it mediates multidrug efflux.
emrK.3000206.D78168.536_1592.173	emrK.3000206.D78168.536_1592.173	1	0	539	390	emrK	1056	1056	98.2	emrK.l15.c30.ctg.1	1465	14.2	0	.	p	.	0	N306D	NONSYN	916	918	AAC	1110	1112	GAC	11;10;10	G;A;C	11;10;10	.	emrK;emrK is a membrane fusion protein that is a homolog of EmrA. Together with the inner membrane transporter EmrY and the outer membrane channel TolC, it mediates multidrug efflux.
emrR.3000516.NC_000913.3.2810769_2811300.3621	emrR.3000516.NC_000913.3.2810769_2811300.3621	1	0	27	334	emrR	531	531	100.0	emrR.l15.c30.ctg.1	907	19.7	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	EmrR is a negative regulator for the EmrAB-TolC multidrug efflux pump in E. coli. Mutations lead to EmrAB-TolC overexpression.;emrR
emrY.3000254.D78168.1591_3130.65	emrY.3000254.D78168.1591_3130.65	1	0	27	650	emrY	1539	1539	99.81	emrY.l15.c30.ctg.1	1962	17.8	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	emrY is a multidrug transport that moves substrates across the inner membrane of the Gram-negative E. coli. It is a homolog of emrB.;emrY
evgA.3000832.NC_002695.3211891_3212506.208	evgA.3000832.NC_002695.3211891_3212506.208	1	0	539	246	evgA	615	615	99.19	evgA.l15.c4.ctg.1	900	14.3	0	.	p	.	0	Q62L	NONSYN	184	186	CAG	225	227	CTG	13;13;12	C;T;G	13;13;12	.	EvgA, when phosphorylated, is a positive regulator for efflux protein complexes emrKY and mdtEF. While usually phosphorylated in a EvgS dependent manner, it can be phosphorylated in the absence of EvgS when overexpressed.;evgA
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	513	1146	evgS	3594	2506	97.77	evgS.l15.c30.ctg.1	2655	17.7	0	.	p	.	0	I366L	NONSYN	1096	1098	ATA	8	10	TTA	1;1;1	T;T;A	1;1;1	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	513	1146	evgS	3594	2506	97.77	evgS.l15.c30.ctg.1	2655	17.7	0	.	p	.	0	Q433K	NONSYN	1297	1299	CAG	209	211	AAA	13;13;13	A;A;A	13;13;13	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	513	1146	evgS	3594	2506	97.77	evgS.l15.c30.ctg.1	2655	17.7	0	.	p	.	0	N678H	NONSYN	2032	2034	AAT	944	946	CAT	17;17;16	C;A;T	17;17;16	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	513	1146	evgS	3594	2506	97.77	evgS.l15.c30.ctg.1	2655	17.7	0	.	p	.	0	N696H	NONSYN	2086	2088	AAT	998	1000	CAT	12;11;11	C;A;T	12;11;11	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	513	1146	evgS	3594	2506	97.77	evgS.l15.c30.ctg.1	2655	17.7	0	.	p	.	0	K702R	NONSYN	2104	2106	AAA	1016	1018	AGA	9;10;10	A;G;A	9;10;10	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	513	1146	evgS	3594	2506	97.77	evgS.l15.c30.ctg.1	2655	17.7	0	.	p	.	0	K707N	NONSYN	2119	2121	AAG	1031	1033	AAT	14;14;14	A;A;T	14;14;14	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	513	1146	evgS	3594	2506	97.77	evgS.l15.c30.ctg.1	2655	17.7	0	.	p	.	0	A756S	NONSYN	2266	2268	GCC	1178	1180	TCC	12;10;10	T;C;C	12;10;10	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	513	1146	evgS	3594	2506	97.77	evgS.l15.c30.ctg.1	2655	17.7	0	.	p	.	0	S811I	NONSYN	2431	2433	AGT	1343	1345	ATT	20;20;21	A;T;T	20;20;21	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	513	1146	evgS	3594	2506	97.77	evgS.l15.c30.ctg.1	2655	17.7	0	.	p	.	0	E818D	NONSYN	2452	2454	GAA	1364	1366	GAT	14;12;13	G;A;T	14;12;13	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	513	1146	evgS	3594	2506	97.77	evgS.l15.c30.ctg.1	2655	17.7	0	.	p	.	0	G856V	NONSYN	2566	2568	GGT	1478	1480	GTT	24;23;23	G;T;T	24;23;23	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	513	1146	evgS	3594	2506	97.77	evgS.l15.c30.ctg.1	2655	17.7	0	.	p	.	0	Q951H	NONSYN	2851	2853	CAA	1763	1765	CAC	24;23;22	C;A;C	24;23;22	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	513	1146	evgS	3594	75	100.0	evgS.l15.c30.ctg.2	271	10.1	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	513	1146	evgS	3594	900	96.89	evgS.l15.c30.ctg.3	900	12.2	0	.	p	.	0	L42V	NONSYN	124	126	CTA	4	6	GTA	5;5;5	G;T;A	5;5;5	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	513	1146	evgS	3594	900	96.89	evgS.l15.c30.ctg.3	900	12.2	0	.	p	.	0	A93T	NONSYN	277	279	GCG	157	159	ACG	10;10;9	A;C;G	10;10;9	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	513	1146	evgS	3594	900	96.89	evgS.l15.c30.ctg.3	900	12.2	0	.	p	.	0	A114E	NONSYN	340	342	GCA	220	222	GAA	13;14;14	G;A;A	13;14;14	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	513	1146	evgS	3594	900	96.89	evgS.l15.c30.ctg.3	900	12.2	0	.	p	.	0	T127A	NONSYN	379	381	ACT	259	261	GCT	14;13;14	G;C;T	14;13;14	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	513	1146	evgS	3594	900	96.89	evgS.l15.c30.ctg.3	900	12.2	0	.	p	.	0	N133D	NONSYN	397	399	AAT	277	279	GAT	12;12;12	G;A;T	12;12;12	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	513	1146	evgS	3594	900	96.89	evgS.l15.c30.ctg.3	900	12.2	0	.	p	.	0	P162S	NONSYN	484	486	CCA	364	366	TCA	12;12;11	T;C;A	12;12;11	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	513	1146	evgS	3594	900	96.89	evgS.l15.c30.ctg.3	900	12.2	0	.	p	.	0	H205Q	NONSYN	613	615	CAC	493	495	CAG	5;5;5	C;A;G	5;5;5	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	513	1146	evgS	3594	900	96.89	evgS.l15.c30.ctg.3	900	12.2	0	.	p	.	0	I251V	NONSYN	751	753	ATT	631	633	GTT	15;14;13	G;T;T	15;14;13	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	513	1146	evgS	3594	900	96.89	evgS.l15.c30.ctg.3	900	12.2	0	.	p	.	0	N303D	NONSYN	907	909	AAT	787	789	GAT	6;6;6	G;A;T	6;6;6	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
folP.3003386.NC_007779.3323917_3324766.2056	folP.3003386.NC_007779.3323917_3324766.2056	1	1	27	514	folP_1	849	849	99.29	folP_1.l15.c4.ctg.1	1239	22.2	1	SNP	p	P64A	0	.	.	190	192	CCA	376	378	CCA	29;26;28	C;C;A	29;25;27	folP.3003386.NC_007779.3323917_3324766.2056:1:1:P64A:.:Point mutations in Escherichia coli dihydropteroate synthase folP prevent sulfonamide antibiotics from inhibiting its role in folate synthesis, thus conferring sulfonamide resistance.	Escherichia coli sulfonamide resistant mutant folP
folP.3003386.NC_007779.3323917_3324766.2056	folP.3003386.NC_007779.3323917_3324766.2056	1	1	27	514	folP_1	849	849	99.29	folP_1.l15.c4.ctg.1	1239	22.2	1	SNP	p	P64S	0	.	.	190	192	CCA	376	378	CCA	29;26;28	C;C;A	29;25;27	folP.3003386.NC_007779.3323917_3324766.2056:1:1:P64S:.:Point mutations in Escherichia coli dihydropteroate synthase folP prevent sulfonamide antibiotics from inhibiting its role in folate synthesis, thus conferring sulfonamide resistance.	Escherichia coli sulfonamide resistant mutant folP
folP.3003386.NC_007779.3323917_3324766.2056	folP.3003386.NC_007779.3323917_3324766.2056	1	1	27	514	folP_1	849	849	99.29	folP_1.l15.c4.ctg.1	1239	22.2	1	SNP	p	P64H	0	.	.	190	192	CCA	376	378	CCA	29;26;28	C;C;A	29;25;27	folP.3003386.NC_007779.3323917_3324766.2056:1:1:P64H:.:Point mutations in Escherichia coli dihydropteroate synthase folP prevent sulfonamide antibiotics from inhibiting its role in folate synthesis, thus conferring sulfonamide resistance.	Escherichia coli sulfonamide resistant mutant folP
folP.3003386.NC_007779.3323917_3324766.2056	folP.3003386.NC_007779.3323917_3324766.2056	1	1	27	514	folP_1	849	849	99.29	folP_1.l15.c4.ctg.1	1239	22.2	1	SNP	p	P64L	0	.	.	190	192	CCA	376	378	CCA	29;26;28	C;C;A	29;25;27	folP.3003386.NC_007779.3323917_3324766.2056:1:1:P64L:.:Point mutations in Escherichia coli dihydropteroate synthase folP prevent sulfonamide antibiotics from inhibiting its role in folate synthesis, thus conferring sulfonamide resistance.	Escherichia coli sulfonamide resistant mutant folP
folP.3003386.NC_007779.3323917_3324766.2056	folP.3003386.NC_007779.3323917_3324766.2056	1	1	27	514	folP_1	849	849	99.29	folP_1.l15.c4.ctg.1	1239	22.2	1	SNP	p	P64R	0	.	.	190	192	CCA	376	378	CCA	29;26;28	C;C;A	29;25;27	folP.3003386.NC_007779.3323917_3324766.2056:1:1:P64R:.:Point mutations in Escherichia coli dihydropteroate synthase folP prevent sulfonamide antibiotics from inhibiting its role in folate synthesis, thus conferring sulfonamide resistance.	Escherichia coli sulfonamide resistant mutant folP
gadE.3003834.NC_000913.3.3658365_3658893.3597	gadE.3003834.NC_000913.3.3658365_3658893.3597	1	0	27	214	gadE	528	528	100.0	gadE.l15.c30.ctg.1	955	12.0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	gadE is a DNA-binding transcriptional activator that regulates the expression of genes involved in acid resistance. It is required for the expression of gadA and gadBC.;gadE
gadW.3003838.CP015085.1.2551711_2552440.3599	gadW.3003838.CP015085.1.2551711_2552440.3599	1	0	528	76	gadW	729	138	95.65	gadW.l15.c30.ctg.1	138	5.5	0	.	p	.	0	K110N	NONSYN	328	330	AAA	10	12	AAT	1;1;1	A;A;T	1;1;1	.	GadW is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance. GadW inhibits GadX-dependent activation. GadW clearly represses gadX and, in situations where GadX is missing, activates gadA and gadBC.;gadW
gadX.3000508.NC_007779.3974604_3975429.615	gadX.3000508.NC_007779.3974604_3975429.615	1	0	539	312	gadX	825	825	97.94	gadX.l6.c17.ctg.1	929	16.3	0	.	p	.	0	F53L	NONSYN	157	159	TTC	208	210	TTA	16;17;17	T;T;A	16;17;17	.	GadX is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance.;gadX
gadX.3000508.NC_007779.3974604_3975429.615	gadX.3000508.NC_007779.3974604_3975429.615	1	0	539	312	gadX	825	825	97.94	gadX.l6.c17.ctg.1	929	16.3	0	.	p	.	0	V79I	NONSYN	235	237	GTT	286	288	ATT	18;18;18	A;T;T	18;18;18	.	GadX is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance.;gadX
gadX.3000508.NC_007779.3974604_3975429.615	gadX.3000508.NC_007779.3974604_3975429.615	1	0	539	312	gadX	825	825	97.94	gadX.l6.c17.ctg.1	929	16.3	0	.	p	.	0	R246G	NONSYN	736	738	AGA	787	789	GGA	18;18;16	G;G;A	18;18;16	.	GadX is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance.;gadX
gadX.3000508.NC_007779.3974604_3975429.615	gadX.3000508.NC_007779.3974604_3975429.615	1	0	539	312	gadX	825	825	97.94	gadX.l6.c17.ctg.1	929	16.3	0	.	p	.	0	S248P	NONSYN	742	744	TCG	793	795	CCG	18;18;19	C;C;G	18;18;19	.	GadX is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance.;gadX
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	1642	gyrA_7	2628	2628	98.71	gyrA_7.l15.c30.ctg.1	2901	30.3	0	.	p	.	0	D678E	NONSYN	2032	2034	GAC	2100	2102	GAA	35;36;34	G;A;A	35;36;34	.	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	1642	gyrA_7	2628	2628	98.71	gyrA_7.l15.c30.ctg.1	2901	30.3	1	SNP	p	S83I	0	.	.	247	249	TCG	315	317	TCG	32;32;31	T;C;G,T	32;31;30,1	gyrA.3003294.U00096.2336792_2339420.2052:1:1:S83I:.:Point mutation of Escherichia coli gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	1642	gyrA_7	2628	2628	98.71	gyrA_7.l15.c30.ctg.1	2901	30.3	1	SNP	p	S83W	0	.	.	247	249	TCG	315	317	TCG	32;32;31	T;C;G,T	32;31;30,1	gyrA.3003294.U00096.2336792_2339420.2052:1:1:S83W:.:Point mutation of Escherichia coli gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	1642	gyrA_7	2628	2628	98.71	gyrA_7.l15.c30.ctg.1	2901	30.3	1	SNP	p	S83L	0	.	.	247	249	TCG	315	317	TCG	32;32;31	T;C;G,T	32;31;30,1	gyrA.3003294.U00096.2336792_2339420.2052:1:1:S83L:.:Point mutation of Escherichia coli gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	1642	gyrA_7	2628	2628	98.71	gyrA_7.l15.c30.ctg.1	2901	30.3	1	SNP	p	D87N	0	.	.	259	261	GAC	327	329	GAC	32;32;32	G,T;A;C	31,1;32;32	gyrA.3003294.U00096.2336792_2339420.2052:1:1:D87N:.:Point mutation of Escherichia coli gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	1642	gyrA_7	2628	2628	98.71	gyrA_7.l15.c30.ctg.1	2901	30.3	1	SNP	p	D87G	0	.	.	259	261	GAC	327	329	GAC	32;32;32	G,T;A;C	31,1;32;32	gyrA.3003294.U00096.2336792_2339420.2052:1:1:D87G:.:Point mutation of Escherichia coli gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	1642	gyrA_7	2628	2628	98.71	gyrA_7.l15.c30.ctg.1	2901	30.3	1	SNP	p	D87H	0	.	.	259	261	GAC	327	329	GAC	32;32;32	G,T;A;C	31,1;32;32	gyrA.3003294.U00096.2336792_2339420.2052:1:1:D87H:.:Point mutation of Escherichia coli gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	1642	gyrA_7	2628	2628	98.71	gyrA_7.l15.c30.ctg.1	2901	30.3	1	SNP	p	D87Y	0	.	.	259	261	GAC	327	329	GAC	32;32;32	G,T;A;C	31,1;32;32	gyrA.3003294.U00096.2336792_2339420.2052:1:1:D87Y:.:Point mutation of Escherichia coli gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	1642	gyrA_7	2628	2628	98.71	gyrA_7.l15.c30.ctg.1	2901	30.3	1	SNP	p	D87V	0	.	.	259	261	GAC	327	329	GAC	32;32;32	G,T;A;C	31,1;32;32	gyrA.3003294.U00096.2336792_2339420.2052:1:1:D87V:.:Point mutation of Escherichia coli gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrB.3003303.AP009048.3760295_3762710.2063	gyrB.3003303.AP009048.3760295_3762710.2063	1	1	27	1532	gyrB_1	2415	2415	99.05	gyrB_1.l15.c4.ctg.1	2827	28.9	1	SNP	p	R136G	0	.	.	406	408	CGC	655	657	CGC	37;37;37	C;G;C	36;37;37	gyrB.3003303.AP009048.3760295_3762710.2063:1:1:R136G:.:Point mutation in Escherichia coli resulting in aminocoumarin resistance	Escherichia coli gyrB conferring resistance to aminocoumarin
gyrB.3003303.AP009048.3760295_3762710.2063	gyrB.3003303.AP009048.3760295_3762710.2063	1	1	27	1532	gyrB_1	2415	2415	99.05	gyrB_1.l15.c4.ctg.1	2827	28.9	1	SNP	p	R136E	0	.	.	406	408	CGC	655	657	CGC	37;37;37	C;G;C	36;37;37	gyrB.3003303.AP009048.3760295_3762710.2063:1:1:R136E:.:Point mutation in Escherichia coli resulting in aminocoumarin resistance	Escherichia coli gyrB conferring resistance to aminocoumarin
gyrB.3003303.AP009048.3760295_3762710.2063	gyrB.3003303.AP009048.3760295_3762710.2063	1	1	27	1532	gyrB_1	2415	2415	99.05	gyrB_1.l15.c4.ctg.1	2827	28.9	1	SNP	p	R136I	0	.	.	406	408	CGC	655	657	CGC	37;37;37	C;G;C	36;37;37	gyrB.3003303.AP009048.3760295_3762710.2063:1:1:R136I:.:Point mutation in Escherichia coli resulting in aminocoumarin resistance	Escherichia coli gyrB conferring resistance to aminocoumarin
gyrB.3003303.AP009048.3760295_3762710.2063	gyrB.3003303.AP009048.3760295_3762710.2063	1	1	27	1532	gyrB_1	2415	2415	99.05	gyrB_1.l15.c4.ctg.1	2827	28.9	1	SNP	p	R136S	0	.	.	406	408	CGC	655	657	CGC	37;37;37	C;G;C	36;37;37	gyrB.3003303.AP009048.3760295_3762710.2063:1:1:R136S:.:Point mutation in Escherichia coli resulting in aminocoumarin resistance	Escherichia coli gyrB conferring resistance to aminocoumarin
gyrB.3003303.AP009048.3760295_3762710.2063	gyrB.3003303.AP009048.3760295_3762710.2063	1	1	27	1532	gyrB_1	2415	2415	99.05	gyrB_1.l15.c4.ctg.1	2827	28.9	1	SNP	p	R136C	0	.	.	406	408	CGC	655	657	CGC	37;37;37	C;G;C	36;37;37	gyrB.3003303.AP009048.3760295_3762710.2063:1:1:R136C:.:Point mutation in Escherichia coli resulting in aminocoumarin resistance	Escherichia coli gyrB conferring resistance to aminocoumarin
gyrB.3003303.AP009048.3760295_3762710.2063	gyrB.3003303.AP009048.3760295_3762710.2063	1	1	27	1532	gyrB_1	2415	2415	99.05	gyrB_1.l15.c4.ctg.1	2827	28.9	1	SNP	p	R136L	0	.	.	406	408	CGC	655	657	CGC	37;37;37	C;G;C	36;37;37	gyrB.3003303.AP009048.3760295_3762710.2063:1:1:R136L:.:Point mutation in Escherichia coli resulting in aminocoumarin resistance	Escherichia coli gyrB conferring resistance to aminocoumarin
gyrB.3003303.AP009048.3760295_3762710.2063	gyrB.3003303.AP009048.3760295_3762710.2063	1	1	27	1532	gyrB_1	2415	2415	99.05	gyrB_1.l15.c4.ctg.1	2827	28.9	1	SNP	p	R136H	0	.	.	406	408	CGC	655	657	CGC	37;37;37	C;G;C	36;37;37	gyrB.3003303.AP009048.3760295_3762710.2063:1:1:R136H:.:Point mutation in Escherichia coli resulting in aminocoumarin resistance	Escherichia coli gyrB conferring resistance to aminocoumarin
kdpE.3003841.NC_000913.3.721055_721733.3608	kdpE.3003841.NC_000913.3.721055_721733.3608	1	0	539	332	kdpE	678	678	98.23	kdpE.l15.c30.ctg.1	1006	17.5	0	.	p	.	0	A72P	NONSYN	214	216	GCG	409	411	CCG	32;33;32	C;C;G	32;33;32	.	kdpE is a transcriptional activator that is part of the two-component system KdpD/KdpE that is studied for its regulatory role in potassium transport and has been identified as an adaptive regulator involved in the virulence and intracellular survival of pathogenic bacteria. kdpE regulates a range of virulence loci through direct promoter binding.;kdpE
kdpE.3003841.NC_000913.3.721055_721733.3608	kdpE.3003841.NC_000913.3.721055_721733.3608	1	0	539	332	kdpE	678	678	98.23	kdpE.l15.c30.ctg.1	1006	17.5	0	.	p	.	0	T123A	NONSYN	367	369	ACC	562	564	GCC	21;21;21	G;C;C	20;21;21	.	kdpE is a transcriptional activator that is part of the two-component system KdpD/KdpE that is studied for its regulatory role in potassium transport and has been identified as an adaptive regulator involved in the virulence and intracellular survival of pathogenic bacteria. kdpE regulates a range of virulence loci through direct promoter binding.;kdpE
leuO.3003843.NC_000913.3.84367_85312.3607	leuO.3003843.NC_000913.3.84367_85312.3607	1	0	539	528	leuO	945	945	99.26	leuO.l15.c4.ctg.1	1379	20.5	0	.	p	.	0	P9S	NONSYN	25	27	CCA	234	236	TCA	11;12;14	T;C;A	11;11;14	.	leuO, a LysR family transcription factor, exists in a wide variety of bacteria of the family Enterobacteriaceae and is involved in the regulation of as yet unidentified genes affecting the stress response and pathogenesis expression.;leuO
marA.3000263.NC_007779.1621287_1621671.579	marA.3000263.NC_007779.1621287_1621671.579	1	0	27	242	marA	384	384	99.74	marA.l15.c30.ctg.1	888	14.5	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	marA;In the presence of antibiotic stress, E. coli overexpresses the global activator protein MarA, which besides inducing MDR efflux pump AcrAB, also down- regulates synthesis of the porin OmpF.
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	531	142	marR	435	430	97.67	marR.l15.c30.ctg.1	519	12.1	1	SNP	p	G103S	1	G103S	NONSYN	307	309	GGC	396	398	AGC	15;14;14	A;G;C	15;13;14	marR.3003378.U00096.1619119_1619554.2097:1:1:G103S:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	531	142	marR	435	430	97.67	marR.l15.c30.ctg.1	519	12.1	1	SNP	p	Y137H	1	Y137H	NONSYN	409	411	TAT	498	500	CAT	5;4;4	C;A;T	5;4;4	marR.3003378.U00096.1619119_1619554.2097:1:1:Y137H:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	531	142	marR	435	430	97.67	marR.l15.c30.ctg.1	519	12.1	1	SNP	p	V45E	0	.	.	133	135	GTG	222	224	GTG	21;21;22	G;T;G	21;21;22	marR.3003378.U00096.1619119_1619554.2097:1:1:V45E:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	531	142	marR	435	430	97.67	marR.l15.c30.ctg.1	519	12.1	1	SNP	p	I49S	0	.	.	145	147	ATC	234	236	ATC	17;17;17	A;T;C	17;17;17	marR.3003378.U00096.1619119_1619554.2097:1:1:I49S:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	531	142	marR	435	430	97.67	marR.l15.c30.ctg.1	519	12.1	1	SNP	p	A70T	0	.	.	208	210	GCA	297	299	GCA	13;12;12	G;C;A	13;12;12	marR.3003378.U00096.1619119_1619554.2097:1:1:A70T:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	531	142	marR	435	430	97.67	marR.l15.c30.ctg.1	519	12.1	1	SNP	p	R73C	0	.	.	217	219	CGT	306	308	CGT	12;11;9	C;G;T	12;11;9	marR.3003378.U00096.1619119_1619554.2097:1:1:R73C:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	531	142	marR	435	430	97.67	marR.l15.c30.ctg.1	519	12.1	1	SNP	p	R73S	0	.	.	217	219	CGT	306	308	CGT	12;11;9	C;G;T	12;11;9	marR.3003378.U00096.1619119_1619554.2097:1:1:R73S:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	531	142	marR	435	430	97.67	marR.l15.c30.ctg.1	519	12.1	1	SNP	p	R77C	0	.	.	229	231	CGC	318	320	CGC	11;11;11	C;G;C	11;11;11	marR.3003378.U00096.1619119_1619554.2097:1:1:R77C:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	531	142	marR	435	430	97.67	marR.l15.c30.ctg.1	519	12.1	1	SNP	p	R77L	0	.	.	229	231	CGC	318	320	CGC	11;11;11	C;G;C	11;11;11	marR.3003378.U00096.1619119_1619554.2097:1:1:R77L:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	531	142	marR	435	430	97.67	marR.l15.c30.ctg.1	519	12.1	1	SNP	p	L78M	0	.	.	232	234	CTG	321	323	CTG	11;11;10	C;T;G	10;10;10	marR.3003378.U00096.1619119_1619554.2097:1:1:L78M:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	531	142	marR	435	430	97.67	marR.l15.c30.ctg.1	519	12.1	1	SNP	p	R94H	0	.	.	280	282	CGC	369	371	CGC	12;10;10	C;G;C	12;10;10	marR.3003378.U00096.1619119_1619554.2097:1:1:R94H:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	531	142	marR	435	430	97.67	marR.l15.c30.ctg.1	519	12.1	1	SNP	p	R94S	0	.	.	280	282	CGC	369	371	CGC	12;10;10	C;G;C	12;10;10	marR.3003378.U00096.1619119_1619554.2097:1:1:R94S:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	531	142	marR	435	430	97.67	marR.l15.c30.ctg.1	519	12.1	1	SNP	p	V96E	0	.	.	286	288	GTA	375	377	GTA	11;11;11	G;T;A,G	11;11;10,1	marR.3003378.U00096.1619119_1619554.2097:1:1:V96E:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	531	424	mdfA	1233	1233	97.0	mdfA.l6.c4.ctg.1	1336	16.7	0	.	p	.	0	S7F	NONSYN	19	21	TCC	21	23	TTC	2;2;2	T;T;C	2;2;2	.	Multidrug translocase MdfA;mdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	531	424	mdfA	1233	1233	97.0	mdfA.l6.c4.ctg.1	1336	16.7	0	.	p	.	0	R36I	NONSYN	106	108	AGG	108	110	ATC	7;6;5	A;T;C	6;6;5	.	Multidrug translocase MdfA;mdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	531	424	mdfA	1233	1233	97.0	mdfA.l6.c4.ctg.1	1336	16.7	0	.	p	.	0	E42A	NONSYN	124	126	GAA	126	128	GCC	2;2;2	G;C;C	2;2;2	.	Multidrug translocase MdfA;mdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	531	424	mdfA	1233	1233	97.0	mdfA.l6.c4.ctg.1	1336	16.7	0	.	p	.	0	N43A	NONSYN	127	129	AAT	129	131	GCG	2;2;3	G;C,T;G	2;0,1;3	.	Multidrug translocase MdfA;mdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	531	424	mdfA	1233	1233	97.0	mdfA.l6.c4.ctg.1	1336	16.7	0	.	p	.	0	E52D	NONSYN	154	156	GAG	156	158	GAT	3;3;3	G;A;T	3;3;3	.	Multidrug translocase MdfA;mdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	531	424	mdfA	1233	1233	97.0	mdfA.l6.c4.ctg.1	1336	16.7	0	.	p	.	0	N59T	NONSYN	175	177	AAC	177	179	ACC	4;4;4	A;C;C	4;4;4	.	Multidrug translocase MdfA;mdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	531	424	mdfA	1233	1233	97.0	mdfA.l6.c4.ctg.1	1336	16.7	0	.	p	.	0	I68L	NONSYN	202	204	ATA	204	206	TTA	9;9;9	T;T;A	9;9;9	.	Multidrug translocase MdfA;mdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	531	424	mdfA	1233	1233	97.0	mdfA.l6.c4.ctg.1	1336	16.7	0	.	p	.	0	H115Q	NONSYN	343	345	CAC	345	347	CAG	20;20;18	C;A;G	20;20;18	.	Multidrug translocase MdfA;mdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	531	424	mdfA	1233	1233	97.0	mdfA.l6.c4.ctg.1	1336	16.7	0	.	p	.	0	D128A	NONSYN	382	384	GAC	384	386	GCC	12;11;11	G;C;C	12;11;11	.	Multidrug translocase MdfA;mdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	531	424	mdfA	1233	1233	97.0	mdfA.l6.c4.ctg.1	1336	16.7	0	.	p	.	0	S163A	NONSYN	487	489	TCG	489	491	GCG	19;19;19	G;C;G	19;19;19	.	Multidrug translocase MdfA;mdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	531	424	mdfA	1233	1233	97.0	mdfA.l6.c4.ctg.1	1336	16.7	0	.	p	.	0	L231V	NONSYN	691	693	CTT	693	695	GTT	10;10;10	G;T;T	6;9;10	.	Multidrug translocase MdfA;mdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	531	424	mdfA	1233	1233	97.0	mdfA.l6.c4.ctg.1	1336	16.7	0	.	p	.	0	R285fs	FSHIFT	853	853	C	855	855	C	17	C	17	.	Multidrug translocase MdfA;mdfA
mdtA.3000792.U00096.2154015_2155263.15	mdtA.3000792.U00096.2154015_2155263.15	1	0	513	454	mdtA	1248	812	97.78	mdtA.l15.c4.ctg.1	934	15.7	0	.	p	.	0	P257T	NONSYN	769	771	CCG	333	335	ACG	15;15;15	A;C;G	15;15;15	.	mdtA;MdtA is the membrane fusion protein of the multidrug efflux complex mdtABC.
mdtA.3000792.U00096.2154015_2155263.15	mdtA.3000792.U00096.2154015_2155263.15	1	0	513	454	mdtA	1248	436	96.56	mdtA.l15.c4.ctg.2	621	14.6	0	.	p	.	0	V12trunc	TRUNC	34	34	G	225	225	G	28	G	28	.	mdtA;MdtA is the membrane fusion protein of the multidrug efflux complex mdtABC.
mdtA.3000792.U00096.2154015_2155263.15	mdtA.3000792.U00096.2154015_2155263.15	1	0	513	454	mdtA	1248	436	96.56	mdtA.l15.c4.ctg.2	621	14.6	0	.	p	.	0	R33Q	NONSYN	97	99	CGG	282	284	CAG	12;13;13	C;A;G	12;13;13	.	mdtA;MdtA is the membrane fusion protein of the multidrug efflux complex mdtABC.
mdtA.3000792.U00096.2154015_2155263.15	mdtA.3000792.U00096.2154015_2155263.15	1	0	513	454	mdtA	1248	436	96.56	mdtA.l15.c4.ctg.2	621	14.6	0	.	p	.	0	T83I	NONSYN	247	249	ACC	432	434	ATC	14;13;12	A;T;C	14;13;12	.	mdtA;MdtA is the membrane fusion protein of the multidrug efflux complex mdtABC.
mdtA.3000792.U00096.2154015_2155263.15	mdtA.3000792.U00096.2154015_2155263.15	1	0	513	454	mdtA	1248	436	96.56	mdtA.l15.c4.ctg.2	621	14.6	0	.	p	.	0	I99M	NONSYN	295	297	ATA	480	482	ATG	10;10;11	A;T;G	10;10;11	.	mdtA;MdtA is the membrane fusion protein of the multidrug efflux complex mdtABC.
mdtA.3000792.U00096.2154015_2155263.15	mdtA.3000792.U00096.2154015_2155263.15	1	0	513	454	mdtA	1248	436	96.56	mdtA.l15.c4.ctg.2	621	14.6	0	.	p	.	0	A130T	NONSYN	388	390	GCC	573	575	ACC	11;10;10	A;C;C	11;10;10	.	mdtA;MdtA is the membrane fusion protein of the multidrug efflux complex mdtABC.
mdtB.3000793.U00096.2155262_2158385.215	mdtB.3000793.U00096.2155262_2158385.215	1	0	539	1812	mdtB	3123	3123	98.98	mdtB.l15.c4.ctg.1	3388	28.7	0	.	p	.	0	A583T	NONSYN	1747	1749	GCC	1896	1898	ACC	34;36;34	A;C;C	34;36;34	.	mdtB;MdtB is a transporter that forms a heteromultimer complex with MdtC to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex.
mdtB.3000793.U00096.2155262_2158385.215	mdtB.3000793.U00096.2155262_2158385.215	1	0	539	1812	mdtB	3123	3123	98.98	mdtB.l15.c4.ctg.1	3388	28.7	0	.	p	.	0	K714Q	NONSYN	2140	2142	AAA	2289	2291	CAA	20;19;20	C;A;A	19;18;19	.	mdtB;MdtB is a transporter that forms a heteromultimer complex with MdtC to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex.
mdtB.3000793.U00096.2155262_2158385.215	mdtB.3000793.U00096.2155262_2158385.215	1	0	539	1812	mdtB	3123	3123	98.98	mdtB.l15.c4.ctg.1	3388	28.7	0	.	p	.	0	N770I	NONSYN	2308	2310	AAT	2457	2459	ATT	17;17;14	A;T;T	17;17;14	.	mdtB;MdtB is a transporter that forms a heteromultimer complex with MdtC to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex.
mdtB.3000793.U00096.2155262_2158385.215	mdtB.3000793.U00096.2155262_2158385.215	1	0	539	1812	mdtB	3123	3123	98.98	mdtB.l15.c4.ctg.1	3388	28.7	0	.	p	.	0	I798V	NONSYN	2392	2394	ATT	2541	2543	GTT	31;31;33	G;T;T	31;31;33	.	mdtB;MdtB is a transporter that forms a heteromultimer complex with MdtC to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex.
mdtB.3000793.U00096.2155262_2158385.215	mdtB.3000793.U00096.2155262_2158385.215	1	0	539	1812	mdtB	3123	3123	98.98	mdtB.l15.c4.ctg.1	3388	28.7	0	.	p	.	0	A834E	NONSYN	2500	2502	GCG	2649	2651	GAG	19;19;18	G;A;G	19;19;18	.	mdtB;MdtB is a transporter that forms a heteromultimer complex with MdtC to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex.
mdtB.3000793.U00096.2155262_2158385.215	mdtB.3000793.U00096.2155262_2158385.215	1	0	539	1812	mdtB	3123	3123	98.98	mdtB.l15.c4.ctg.1	3388	28.7	0	.	p	.	0	L910M	NONSYN	2728	2730	CTG	2877	2879	ATG	10;10;11	A;T;G	10;10;11	.	mdtB;MdtB is a transporter that forms a heteromultimer complex with MdtC to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex.
mdtB.3000793.U00096.2155262_2158385.215	mdtB.3000793.U00096.2155262_2158385.215	1	0	539	1812	mdtB	3123	3123	98.98	mdtB.l15.c4.ctg.1	3388	28.7	0	.	p	.	0	E955D	NONSYN	2863	2865	GAG	3012	3014	GAT	29;28;29	G;A;T	28;27;29	.	mdtB;MdtB is a transporter that forms a heteromultimer complex with MdtC to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex.
mdtC.3000794.U00096.2158385_2161463.257	mdtC.3000794.U00096.2158385_2161463.257	1	0	531	1608	mdtC	3078	2970	97.64	mdtC.l15.c30.ctg.1	3026	27.3	0	.	p	.	0	I46M	NONSYN	136	138	ATC	73	75	ATG	9;9;10	A;T;G	9;9;10	.	MdtC is a transporter that forms a heteromultimer complex with MdtB to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex. In the absence of MdtB, MdtC can form a homomultimer complex that results in a functioning efflux complex with a narrower drug specificity.;mdtC
mdtC.3000794.U00096.2158385_2161463.257	mdtC.3000794.U00096.2158385_2161463.257	1	0	531	1608	mdtC	3078	2970	97.64	mdtC.l15.c30.ctg.1	3026	27.3	0	.	p	.	0	V208I	NONSYN	622	624	GTC	559	561	ATC	35;35;34	A;T;C	35;35;34	.	MdtC is a transporter that forms a heteromultimer complex with MdtB to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex. In the absence of MdtB, MdtC can form a homomultimer complex that results in a functioning efflux complex with a narrower drug specificity.;mdtC
mdtC.3000794.U00096.2158385_2161463.257	mdtC.3000794.U00096.2158385_2161463.257	1	0	531	1608	mdtC	3078	2970	97.64	mdtC.l15.c30.ctg.1	3026	27.3	0	.	p	.	0	G972T	NONSYN	2914	2916	GGC	2851	2853	ACC	2;2;2	A;C;C	2;2;2	.	MdtC is a transporter that forms a heteromultimer complex with MdtB to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex. In the absence of MdtB, MdtC can form a homomultimer complex that results in a functioning efflux complex with a narrower drug specificity.;mdtC
mdtC.3000794.U00096.2158385_2161463.257	mdtC.3000794.U00096.2158385_2161463.257	1	0	531	1608	mdtC	3078	2970	97.64	mdtC.l15.c30.ctg.1	3026	27.3	0	.	p	.	0	D974V	NONSYN	2920	2922	GAC	2857	2859	GTC	3;3;3	G;T;C	3;3;3	.	MdtC is a transporter that forms a heteromultimer complex with MdtB to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex. In the absence of MdtB, MdtC can form a homomultimer complex that results in a functioning efflux complex with a narrower drug specificity.;mdtC
mdtC.3000794.U00096.2158385_2161463.257	mdtC.3000794.U00096.2158385_2161463.257	1	0	531	1608	mdtC	3078	2970	97.64	mdtC.l15.c30.ctg.1	3026	27.3	0	.	p	.	0	S976A	NONSYN	2926	2928	TCG	2863	2865	GCG	3;3;3	G;C;G	3;3;3	.	MdtC is a transporter that forms a heteromultimer complex with MdtB to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex. In the absence of MdtB, MdtC can form a homomultimer complex that results in a functioning efflux complex with a narrower drug specificity.;mdtC
mdtC.3000794.U00096.2158385_2161463.257	mdtC.3000794.U00096.2158385_2161463.257	1	0	531	1608	mdtC	3078	2970	97.64	mdtC.l15.c30.ctg.1	3026	27.3	0	.	p	.	0	Q980R	NONSYN	2938	2940	CAA	2875	2877	CGT	4;4;4	C;G;T	4;4;4	.	MdtC is a transporter that forms a heteromultimer complex with MdtB to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex. In the absence of MdtB, MdtC can form a homomultimer complex that results in a functioning efflux complex with a narrower drug specificity.;mdtC
mdtC.3000794.U00096.2158385_2161463.257	mdtC.3000794.U00096.2158385_2161463.257	1	0	531	1608	mdtC	3078	2970	97.64	mdtC.l15.c30.ctg.1	3026	27.3	0	.	p	.	0	T985G	NONSYN	2953	2955	ACC	2890	2892	GGC	5;5;4	G;G;C	5;5;4	.	MdtC is a transporter that forms a heteromultimer complex with MdtB to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex. In the absence of MdtB, MdtC can form a homomultimer complex that results in a functioning efflux complex with a narrower drug specificity.;mdtC
mdtC.3000794.U00096.2158385_2161463.257	mdtC.3000794.U00096.2158385_2161463.257	1	0	531	1608	mdtC	3078	2970	97.64	mdtC.l15.c30.ctg.1	3026	27.3	0	.	p	.	0	I986M	NONSYN	2956	2958	ATT	2893	2895	ATG	4;4;4	A;T;G	4;4;4	.	MdtC is a transporter that forms a heteromultimer complex with MdtB to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex. In the absence of MdtB, MdtC can form a homomultimer complex that results in a functioning efflux complex with a narrower drug specificity.;mdtC
mdtC.3000794.U00096.2158385_2161463.257	mdtC.3000794.U00096.2158385_2161463.257	1	0	531	1608	mdtC	3078	2970	97.64	mdtC.l15.c30.ctg.1	3026	27.3	0	.	p	.	0	V991I	NONSYN	2971	2973	GTA	2908	2910	ATT	4;4;5	A;T;T	4;4;5	.	MdtC is a transporter that forms a heteromultimer complex with MdtB to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex. In the absence of MdtB, MdtC can form a homomultimer complex that results in a functioning efflux complex with a narrower drug specificity.;mdtC
mdtC.3000794.U00096.2158385_2161463.257	mdtC.3000794.U00096.2158385_2161463.257	1	0	531	1608	mdtC	3078	2970	97.64	mdtC.l15.c30.ctg.1	3026	27.3	0	.	p	.	0	M992V	NONSYN	2974	2976	ATG	2911	2913	GTC	5;5;5	G;T;C	5;5;5	.	MdtC is a transporter that forms a heteromultimer complex with MdtB to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex. In the absence of MdtB, MdtC can form a homomultimer complex that results in a functioning efflux complex with a narrower drug specificity.;mdtC
mdtC.3000794.U00096.2158385_2161463.257	mdtC.3000794.U00096.2158385_2161463.257	1	0	531	1608	mdtC	3078	2970	97.64	mdtC.l15.c30.ctg.1	3026	27.3	0	.	p	.	0	L995V	NONSYN	2983	2985	CTC	2920	2922	GTG	10;10;10	G,C;T;G,T	6,4;10;6,4	.	MdtC is a transporter that forms a heteromultimer complex with MdtB to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex. In the absence of MdtB, MdtC can form a homomultimer complex that results in a functioning efflux complex with a narrower drug specificity.;mdtC
mdtC.3000794.U00096.2158385_2161463.257	mdtC.3000794.U00096.2158385_2161463.257	1	0	531	1608	mdtC	3078	2970	97.64	mdtC.l15.c30.ctg.1	3026	27.3	0	.	p	.	0	Y999F	NONSYN	2995	2997	TAT	2932	2934	TTC	11;11;10	T;T,A;C,T	11;5,6;4,6	.	MdtC is a transporter that forms a heteromultimer complex with MdtB to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex. In the absence of MdtB, MdtC can form a homomultimer complex that results in a functioning efflux complex with a narrower drug specificity.;mdtC
mdtC.3000794.U00096.2158385_2161463.257	mdtC.3000794.U00096.2158385_2161463.257	1	0	531	1608	mdtC	3078	2970	97.64	mdtC.l15.c30.ctg.1	3026	27.3	0	.	p	.	0	V1004I	NONSYN	3010	3012	GTG	2947	2949	ATT	10;10;10	A,G;T;T,G	4,6;10;4,5	.	MdtC is a transporter that forms a heteromultimer complex with MdtB to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex. In the absence of MdtB, MdtC can form a homomultimer complex that results in a functioning efflux complex with a narrower drug specificity.;mdtC
mdtC.3000794.U00096.2158385_2161463.257	mdtC.3000794.U00096.2158385_2161463.257	1	0	531	1608	mdtC	3078	2970	97.64	mdtC.l15.c30.ctg.1	3026	27.3	0	.	p	.	0	F1007L	NONSYN	3019	3021	TTT	2956	2958	CTG	6;6;6	C,T;T;G,T	3,3;6;3,3	.	MdtC is a transporter that forms a heteromultimer complex with MdtB to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex. In the absence of MdtB, MdtC can form a homomultimer complex that results in a functioning efflux complex with a narrower drug specificity.;mdtC
mdtD.3001330.U00096.2161463_2162879.299	mdtD.3001330.U00096.2161463_2162879.299	1	0	539	724	mdtD	1416	1416	98.38	mdtD.l15.c30.ctg.1	1763	22.0	0	.	p	.	0	D3E	NONSYN	7	9	GAT	149	151	GAA	11;11;11	G;A;A	11;11;11	.	Efflux pump mdtD;mdtD
mdtD.3001330.U00096.2161463_2162879.299	mdtD.3001330.U00096.2161463_2162879.299	1	0	539	724	mdtD	1416	1416	98.38	mdtD.l15.c30.ctg.1	1763	22.0	0	.	p	.	0	T226A	NONSYN	676	678	ACG	818	820	GCG	37;38;37	G;C;G	37;38;37	.	Efflux pump mdtD;mdtD
mdtD.3001330.U00096.2161463_2162879.299	mdtD.3001330.U00096.2161463_2162879.299	1	0	539	724	mdtD	1416	1416	98.38	mdtD.l15.c30.ctg.1	1763	22.0	0	.	p	.	0	V340I	NONSYN	1018	1020	GTC	1160	1162	ATC	21;22;22	A;T;C	21;21;22	.	Efflux pump mdtD;mdtD
mdtD.3001330.U00096.2161463_2162879.299	mdtD.3001330.U00096.2161463_2162879.299	1	0	539	724	mdtD	1416	1416	98.38	mdtD.l15.c30.ctg.1	1763	22.0	0	.	p	.	0	L441F	NONSYN	1321	1323	TTG	1463	1465	TTT	19;20;20	T;T;T	19;20;20	.	Efflux pump mdtD;mdtD
mdtE.3000795.AP009048.3980025_3981183.753	mdtE.3000795.AP009048.3980025_3981183.753	1	0	27	792	mdtE	1158	1158	99.31	mdtE.l15.c4.ctg.1	1625	26.1	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	mdtE;MdtE is the membrane fusion protein of the MdtEF multidrug efflux complex. It shares 70% sequence similarity with AcrA.
mdtF.3000796.U00096.3660413_3663527.286	mdtF.3000796.U00096.3660413_3663527.286	1	0	539	1900	mdtF	3114	3114	98.52	mdtF.l6.c4.ctg.1	3603	28.2	0	.	p	.	0	A295T	NONSYN	883	885	GCC	1150	1152	ACC	25;25;24	A;C;C	25;23;24	.	mdtF;MdtF is the multidrug inner membrane transporter for the MdtEF-TolC efflux complex.
mdtF.3000796.U00096.3660413_3663527.286	mdtF.3000796.U00096.3660413_3663527.286	1	0	539	1900	mdtF	3114	3114	98.52	mdtF.l6.c4.ctg.1	3603	28.2	0	.	p	.	0	N709D	NONSYN	2125	2127	AAT	2392	2394	GAC	46;43;41	G;A;C	46;43;41	.	mdtF;MdtF is the multidrug inner membrane transporter for the MdtEF-TolC efflux complex.
mdtG.3001329.NC_007779.1115840_1117067.599	mdtG.3001329.NC_007779.1115840_1117067.599	1	0	513	592	mdtG	1227	176	99.43	mdtG.l15.c4.ctg.1	179	17.2	0	.	p	.	0	E5G	NONSYN	13	15	GAA	7	9	GGA	3;4;4	G;G;A	3;4;4	.	Efflux protien mdtG.;mdtG
mdtG.3001329.NC_007779.1115840_1117067.599	mdtG.3001329.NC_007779.1115840_1117067.599	1	0	513	592	mdtG	1227	1047	99.33	mdtG.l15.c4.ctg.2	1465	17.2	0	.	p	.	0	V200I	NONSYN	598	600	GTC	629	631	ATC	22;22;22	A;T;C	22;22;22	.	Efflux protien mdtG.;mdtG
mdtH.3001216.U00096.1124117_1125326.120	mdtH.3001216.U00096.1124117_1125326.120	1	0	539	640	mdtH	1209	1209	98.18	mdtH.l15.c4.ctg.1	1534	22.3	0	.	p	.	0	G134C	NONSYN	400	402	GGT	584	586	TGT	31;32;32	T;G;T	31;32;32	.	Multidrug resistance protein MdtH;mdtH
mdtH.3001216.U00096.1124117_1125326.120	mdtH.3001216.U00096.1124117_1125326.120	1	0	539	640	mdtH	1209	1209	98.18	mdtH.l15.c4.ctg.1	1534	22.3	0	.	p	.	0	S324L	NONSYN	970	972	TCG	1154	1156	TTG	19;20;21	T;T;G	19;20;21	.	Multidrug resistance protein MdtH;mdtH
mdtH.3001216.U00096.1124117_1125326.120	mdtH.3001216.U00096.1124117_1125326.120	1	0	539	640	mdtH	1209	1209	98.18	mdtH.l15.c4.ctg.1	1534	22.3	0	.	p	.	0	A394T	NONSYN	1180	1182	GCG	1364	1366	ACG	10;10;10	A;C;G	10;10;10	.	Multidrug resistance protein MdtH;mdtH
mdtL.3001215.U00096.3891614_3892790.621	mdtL.3001215.U00096.3891614_3892790.621	1	0	539	660	mdtL	1176	1176	98.38	mdtL.l15.c4.ctg.1	1613	21.9	0	.	p	.	0	A185S	NONSYN	553	555	GCC	765	767	TCC	20;21;20	T,C;C;C	19,1;21;20	.	mdtL;Multidrug resistance protein MdtL
mdtN.3003548.AP009048.4306556_4307588.3298	mdtN.3003548.AP009048.4306556_4307588.3298	1	0	539	508	mdtN	1032	1032	98.06	mdtN.l6.c4.ctg.1	1477	18.4	0	.	p	.	0	V119I	NONSYN	355	357	GTT	547	549	ATT	24;23;22	A;T;T	24;23;22	.	mdtN;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride.
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	1130	mdtO	2052	2052	98.1	mdtO.l6.c30.ctg.1	2484	24.4	0	.	p	.	0	V11M	NONSYN	31	33	GTG	245	247	ATG	16;14;15	A;T;G	16;14;15	.	mdtO;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	1130	mdtO	2052	2052	98.1	mdtO.l6.c30.ctg.1	2484	24.4	0	.	p	.	0	T33I	NONSYN	97	99	ACC	311	313	ATC	22;21;20	A;T;C	21;21;20	.	mdtO;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	1130	mdtO	2052	2052	98.1	mdtO.l6.c30.ctg.1	2484	24.4	0	.	p	.	0	C116R	NONSYN	346	348	TGC	560	562	CGC	34;35;35	C;G;C	32;35;35	.	mdtO;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	1130	mdtO	2052	2052	98.1	mdtO.l6.c30.ctg.1	2484	24.4	0	.	p	.	0	N238S	NONSYN	712	714	AAC	926	928	AGC	23;24;25	A;G;C	23;24;25	.	mdtO;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	1130	mdtO	2052	2052	98.1	mdtO.l6.c30.ctg.1	2484	24.4	0	.	p	.	0	M305V	NONSYN	913	915	ATG	1127	1129	GTG	22;22;22	G;T;G	22;20;21	.	mdtO;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	1130	mdtO	2052	2052	98.1	mdtO.l6.c30.ctg.1	2484	24.4	0	.	p	.	0	D326N	NONSYN	976	978	GAC	1190	1192	AAC	9;9;9	A;A;C	9;7;9	.	mdtO;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	1130	mdtO	2052	2052	98.1	mdtO.l6.c30.ctg.1	2484	24.4	0	.	p	.	0	A341V	NONSYN	1021	1023	GCC	1235	1237	GTC	26;25;26	G;T;C	26;25;26	.	mdtO;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	1130	mdtO	2052	2052	98.1	mdtO.l6.c30.ctg.1	2484	24.4	0	.	p	.	0	M351I	NONSYN	1051	1053	ATG	1265	1267	ATA	32;33;32	A;T;A	32;33;31	.	mdtO;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	1130	mdtO	2052	2052	98.1	mdtO.l6.c30.ctg.1	2484	24.4	0	.	p	.	0	A387S	NONSYN	1159	1161	GCT	1373	1375	TCT	21;21;22	T;C;T	21;21;22	.	mdtO;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	1130	mdtO	2052	2052	98.1	mdtO.l6.c30.ctg.1	2484	24.4	0	.	p	.	0	T516A	NONSYN	1546	1548	ACG	1760	1762	GCG	22;21;23	G;C;G	22;21;23	.	mdtO;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	1130	mdtO	2052	2052	98.1	mdtO.l6.c30.ctg.1	2484	24.4	0	.	p	.	0	L587I	NONSYN	1759	1761	CTT	1973	1975	ATC	27;27;29	A;T;C	27;27;29	.	mdtO;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	539	638	mdtP	1467	1467	97.96	mdtP.l15.c30.ctg.1	1625	20.0	0	.	p	.	0	S129A	NONSYN	385	387	TCA	482	484	GCG	20;21;21	G;C;G	20;21;21	.	mdtP;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	539	638	mdtP	1467	1467	97.96	mdtP.l15.c30.ctg.1	1625	20.0	0	.	p	.	0	A187T	NONSYN	559	561	GCC	656	658	ACC	14;14;13	A;C;C	14;14;13	.	mdtP;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	539	638	mdtP	1467	1467	97.96	mdtP.l15.c30.ctg.1	1625	20.0	0	.	p	.	0	H211R	NONSYN	631	633	CAC	728	730	CGC	21;21;21	C;G;C	21;21;21	.	mdtP;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	539	638	mdtP	1467	1467	97.96	mdtP.l15.c30.ctg.1	1625	20.0	0	.	p	.	0	V250A	NONSYN	748	750	GTT	845	847	GCT	16;16;16	G;C;T	15;16;16	.	mdtP;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	539	638	mdtP	1467	1467	97.96	mdtP.l15.c30.ctg.1	1625	20.0	0	.	p	.	0	R278K	NONSYN	832	834	AGA	929	931	AAA	15;12;12	A;A;A	15;12;12	.	mdtP;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	539	638	mdtP	1467	1467	97.96	mdtP.l15.c30.ctg.1	1625	20.0	0	.	p	.	0	Q284R	NONSYN	850	852	CAA	947	949	CGA	12;12;13	C;G;A	12;12;13	.	mdtP;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	539	638	mdtP	1467	1467	97.96	mdtP.l15.c30.ctg.1	1625	20.0	0	.	p	.	0	S339A	NONSYN	1015	1017	TCC	1112	1114	GCC	17;16;16	G;C;C	17;16;16	.	mdtP;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	539	638	mdtP	1467	1467	97.96	mdtP.l15.c30.ctg.1	1625	20.0	0	.	p	.	0	H343D	NONSYN	1027	1029	CAT	1124	1126	GAT	17;17;17	G;A;T	17;17;17	.	mdtP;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	539	638	mdtP	1467	1467	97.96	mdtP.l15.c30.ctg.1	1625	20.0	0	.	p	.	0	G482A	NONSYN	1444	1446	GGT	1541	1543	GCT	14;13;11	G;C;T	14;13;11	.	mdtP;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mfd.3003844.NC_000913.3.1170517_1173964.3609	mfd.3003844.NC_000913.3.1170517_1173964.3609	1	0	539	1890	mfd	3447	3447	99.16	mfd.l15.c4.ctg.1	3795	26.7	0	.	p	.	0	T437K	NONSYN	1309	1311	ACG	1470	1472	AAG	24;25;23	A;A;G	23;25;23	.	mfd dissociates transcription elongation complexes blocked at nonpairing lesions and mediates recruitment of DNA repair proteins. The Mfd (mutation frequency decline) protein, also known as transcription-repair coupling factor, is responsible for ATP-dependent removal of stalled RNA polymerase from DNA lesions by inducing forward movement of the RNA polymerase and subsequent recruitment of nucleotide excision repair machinery to the sites of the lesions.;mfd
mfd.3003844.NC_000913.3.1170517_1173964.3609	mfd.3003844.NC_000913.3.1170517_1173964.3609	1	0	539	1890	mfd	3447	3447	99.16	mfd.l15.c4.ctg.1	3795	26.7	0	.	p	.	0	M796L	NONSYN	2386	2388	ATG	2547	2549	CTG	29;29;28	C;T;G	29;29;28	.	mfd dissociates transcription elongation complexes blocked at nonpairing lesions and mediates recruitment of DNA repair proteins. The Mfd (mutation frequency decline) protein, also known as transcription-repair coupling factor, is responsible for ATP-dependent removal of stalled RNA polymerase from DNA lesions by inducing forward movement of the RNA polymerase and subsequent recruitment of nucleotide excision repair machinery to the sites of the lesions.;mfd
mgrB.3003820.NC_000913.3.1908622_1908766.3586	mgrB.3003820.NC_000913.3.1908622_1908766.3586	1	0	27	96	mgrB	144	144	100.0	mgrB.l15.c4.ctg.3	178	14.8	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	mgrB;mgrB is a small transmembrane protein produced in the PhoPQ signalling system. It acts as a negative regulator in this system. Inactivation or down-regulation of mgrB confers colistin resistance by absence as shown in Klebsiella pneumoniae
msbA.3003950.NC_000913.3.966620_968369.3754	msbA.3003950.NC_000913.3.966620_968369.3754	1	0	539	1070	msbA	1749	1749	98.68	msbA.l15.c30.ctg.1	2168	26.5	0	.	p	.	0	S278N	NONSYN	832	834	AGC	1039	1041	AAC	27;26;27	A;A;C	26;25;26	.	msbA;MsbA is a multidrug resistance transporter homolog from E. coli and belongs to a superfamily of transporters that contain an adenosine triphosphate (ATP) binding cassette (ABC) which is also called a nucleotide-binding domain (NBD). MsbA is a member of the MDR-ABC transporter group by sequence homology. MsbA transports lipid A, a major component of the bacterial outer cell membrane, and is the only bacterial ABC transporter that is essential for cell viability.
msbA.3003950.NC_000913.3.966620_968369.3754	msbA.3003950.NC_000913.3.966620_968369.3754	1	0	539	1070	msbA	1749	1749	98.68	msbA.l15.c30.ctg.1	2168	26.5	0	.	p	.	0	M460I	NONSYN	1378	1380	ATG	1585	1587	ATA	28;28;28	A;T;A	28;28;28	.	msbA;MsbA is a multidrug resistance transporter homolog from E. coli and belongs to a superfamily of transporters that contain an adenosine triphosphate (ATP) binding cassette (ABC) which is also called a nucleotide-binding domain (NBD). MsbA is a member of the MDR-ABC transporter group by sequence homology. MsbA transports lipid A, a major component of the bacterial outer cell membrane, and is the only bacterial ABC transporter that is essential for cell viability.
murA.3003775.CP009072.1414817_1416077.3548	murA.3003775.CP009072.1414817_1416077.3548	1	1	27	814	murA_12	1260	1260	98.49	murA_12.l15.c30.ctg.1	1653	26.4	1	SNP	p	D369N	0	.	.	1105	1107	GAT	1301	1303	GAT	36;36;36	G;A;T	36;36;36	murA.3003775.CP009072.1414817_1416077.3548:1:1:D369N:.:murA or UDP-N-acetylglucosamine enolpyruvyl transferase catalyses the initial step in peptidoglycan biosynthesis and is inhibited by fosfomycin. Overexpression of murA through mutations such as Asp369Asn and Leu370Ile confers fosfomycin resistance. Extensive evidence has shown the significance of C115 mutations in conferring fosfomycin resistance since this residue represents a primary binding site for the antibiotic across many species.	Escherichia coli mutant murA conferring resistance to fosfomycin
murA.3003775.CP009072.1414817_1416077.3548	murA.3003775.CP009072.1414817_1416077.3548	1	1	27	814	murA_12	1260	1260	98.49	murA_12.l15.c30.ctg.1	1653	26.4	1	SNP	p	L370I	0	.	.	1108	1110	CTG	1304	1306	CTG	37;36;33	C;T;G	37;35;33	murA.3003775.CP009072.1414817_1416077.3548:1:1:L370I:.:murA or UDP-N-acetylglucosamine enolpyruvyl transferase catalyses the initial step in peptidoglycan biosynthesis and is inhibited by fosfomycin. Overexpression of murA through mutations such as Asp369Asn and Leu370Ile confers fosfomycin resistance. Extensive evidence has shown the significance of C115 mutations in conferring fosfomycin resistance since this residue represents a primary binding site for the antibiotic across many species.	Escherichia coli mutant murA conferring resistance to fosfomycin
nfsA.3003751.NC_000913.3.891183_891906.3520	nfsA.3003751.NC_000913.3.891183_891906.3520	1	1	528	232	nfsA	723	405	99.01	nfsA.l15.c4.ctg.1	802	15.1	0	.	p	.	0	R27C	NONSYN	79	81	CGT	278	280	TGT	19;17;17	T;G;T	19;17;17	.	Escherichia coli nfsA mutations conferring resistance to nitrofurantoin
nfsA.3003751.NC_000913.3.891183_891906.3520	nfsA.3003751.NC_000913.3.891183_891906.3520	1	1	528	232	nfsA	723	405	99.01	nfsA.l15.c4.ctg.1	802	15.1	0	.	p	.	0	I117T	NONSYN	349	351	ATC	548	550	ACC	18;18;19	A;C;C	18;18;19	.	Escherichia coli nfsA mutations conferring resistance to nitrofurantoin
nfsA.3003751.NC_000913.3.891183_891906.3520	nfsA.3003751.NC_000913.3.891183_891906.3520	1	1	528	232	nfsA	723	405	99.01	nfsA.l15.c4.ctg.1	802	15.1	1	SNP	p	R15C	0	.	.	43	45	CGC	242	244	CGC	28;26;26	C;G;C	28;26;26	nfsA.3003751.NC_000913.3.891183_891906.3520:1:1:R15C:.:nfsA encodes the major oxygen-insesitive nitroreductase in E. coli. The first step of resistance to nitrofurazone is mutation of nfsA.	Escherichia coli nfsA mutations conferring resistance to nitrofurantoin
nfsA.3003751.NC_000913.3.891183_891906.3520	nfsA.3003751.NC_000913.3.891183_891906.3520	1	1	528	232	nfsA	723	405	99.01	nfsA.l15.c4.ctg.1	802	15.1	1	SNP	p	S33R	0	.	.	97	99	AGC	296	298	AGC	16;17;17	A;G;C	16;17;17	nfsA.3003751.NC_000913.3.891183_891906.3520:1:1:S33R:.:nfsA encodes the major oxygen-insesitive nitroreductase in E. coli. The first step of resistance to nitrofurazone is mutation of nfsA.	Escherichia coli nfsA mutations conferring resistance to nitrofurantoin
nfsA.3003751.NC_000913.3.891183_891906.3520	nfsA.3003751.NC_000913.3.891183_891906.3520	1	1	528	232	nfsA	723	405	99.01	nfsA.l15.c4.ctg.1	802	15.1	1	SNP	p	G131D	0	.	.	391	393	GGC	590	592	GGC	15;14;15	G;G;C	15;14;15	nfsA.3003751.NC_000913.3.891183_891906.3520:1:1:G131D:.:nfsA encodes the major oxygen-insesitive nitroreductase in E. coli. The first step of resistance to nitrofurazone is mutation of nfsA.	Escherichia coli nfsA mutations conferring resistance to nitrofurantoin
ompF.3003390.NC_007779.986315_987404.2075	ompF.3003390.NC_007779.986315_987404.2075	1	1	539	658	ompF	1089	1089	99.91	ompF.l15.c30.ctg.1	1511	23.3	0	.	p	.	0	D312E	NONSYN	934	936	GAT	1134	1136	GAG	43;42;42	G;A;G	43;42;42	.	Escherichia coli ompF mutants
ompF.3003390.NC_007779.986315_987404.2075	ompF.3003390.NC_007779.986315_987404.2075	1	1	539	658	ompF	1089	1089	99.91	ompF.l15.c30.ctg.1	1511	23.3	1	SNP	p	G141E	0	.	.	421	423	GGT	621	623	GGT	33;33;33	G;G;T	33;33;33	ompF.3003390.NC_007779.986315_987404.2075:1:1:G141E:.:Mutant forms of the Escherichia coli outer membrane porin OmpF result in reduced permeability to antibiotics.	Escherichia coli ompF mutants
ompF.3003390.NC_007779.986315_987404.2075	ompF.3003390.NC_007779.986315_987404.2075	1	1	539	658	ompF	1089	1089	99.91	ompF.l15.c30.ctg.1	1511	23.3	1	SNP	p	G141D	0	.	.	421	423	GGT	621	623	GGT	33;33;33	G;G;T	33;33;33	ompF.3003390.NC_007779.986315_987404.2075:1:1:G141D:.:Mutant forms of the Escherichia coli outer membrane porin OmpF result in reduced permeability to antibiotics.	Escherichia coli ompF mutants
ompF.3003390.NC_007779.986315_987404.2075	ompF.3003390.NC_007779.986315_987404.2075	1	1	539	658	ompF	1089	1089	99.91	ompF.l15.c30.ctg.1	1511	23.3	1	SNP	p	R154D	0	.	.	460	462	CGT	660	662	CGT	28;27;27	C;G;T	28;27;27	ompF.3003390.NC_007779.986315_987404.2075:1:1:R154D:.:Mutant forms of the Escherichia coli outer membrane porin OmpF result in reduced permeability to antibiotics.	Escherichia coli ompF mutants
ompF.3003390.NC_007779.986315_987404.2075	ompF.3003390.NC_007779.986315_987404.2075	1	1	539	658	ompF	1089	1089	99.91	ompF.l15.c30.ctg.1	1511	23.3	1	SNP	p	R154A	0	.	.	460	462	CGT	660	662	CGT	28;27;27	C;G;T	28;27;27	ompF.3003390.NC_007779.986315_987404.2075:1:1:R154A:.:Mutant forms of the Escherichia coli outer membrane porin OmpF result in reduced permeability to antibiotics.	Escherichia coli ompF mutants
parC.3003941.NC_004337.2.3159154_3161413.3742	parC.3003941.NC_004337.2.3159154_3161413.3742	1	1	539	1594	parC_2	2259	2259	99.2	parC_2.l15.c4.ctg.1	2696	31.7	0	.	p	.	0	A533V	NONSYN	1597	1599	GCG	1827	1829	GTG	40;42;41	G;T;G	40;42;41	.	Shigella flexneri parC conferring resistance to fluoroquinolones
parC.3003941.NC_004337.2.3159154_3161413.3742	parC.3003941.NC_004337.2.3159154_3161413.3742	1	1	539	1594	parC_2	2259	2259	99.2	parC_2.l15.c4.ctg.1	2696	31.7	0	.	p	.	0	P542S	NONSYN	1624	1626	CCG	1854	1856	TCG	41;42;42	T;C;G	39;40;41	.	Shigella flexneri parC conferring resistance to fluoroquinolones
parC.3003941.NC_004337.2.3159154_3161413.3742	parC.3003941.NC_004337.2.3159154_3161413.3742	1	1	539	1594	parC_2	2259	2259	99.2	parC_2.l15.c4.ctg.1	2696	31.7	0	.	p	.	0	S747N	NONSYN	2239	2241	AGC	2469	2471	AAC	28;29;29	A;A;C	28;29;29	.	Shigella flexneri parC conferring resistance to fluoroquinolones
parC.3003941.NC_004337.2.3159154_3161413.3742	parC.3003941.NC_004337.2.3159154_3161413.3742	1	1	539	1594	parC_2	2259	2259	99.2	parC_2.l15.c4.ctg.1	2696	31.7	1	SNP	p	A85T	0	.	.	253	255	GCG	483	485	GCG	26;27;25	G;C;G	26;27;25	parC.3003941.NC_004337.2.3159154_3161413.3742:1:1:A85T:.:Point mutation in parC conferring resistance to fluoroquinolone antibiotics in Shigella flexneri,	Shigella flexneri parC conferring resistance to fluoroquinolones
parC.3003941.NC_004337.2.3159154_3161413.3742	parC.3003941.NC_004337.2.3159154_3161413.3742	1	1	539	1594	parC_2	2259	2259	99.2	parC_2.l15.c4.ctg.1	2696	31.7	1	SNP	p	D111H	0	.	.	331	333	GAT	561	563	GAT	25;26;28	G;A;T	25;26;27	parC.3003941.NC_004337.2.3159154_3161413.3742:1:1:D111H:.:Point mutation in parC conferring resistance to fluoroquinolone antibiotics in Shigella flexneri,	Shigella flexneri parC conferring resistance to fluoroquinolones
parC.3003941.NC_004337.2.3159154_3161413.3742	parC.3003941.NC_004337.2.3159154_3161413.3742	1	1	539	1594	parC_2	2259	2259	99.2	parC_2.l15.c4.ctg.1	2696	31.7	1	SNP	p	S129P	0	.	.	385	387	TCC	615	617	TCC	36;34;35	T;C;C	35;34;35	parC.3003941.NC_004337.2.3159154_3161413.3742:1:1:S129P:.:Point mutation in parC conferring resistance to fluoroquinolone antibiotics in Shigella flexneri,	Shigella flexneri parC conferring resistance to fluoroquinolones
parE.3003316.NC_007779.3172159_3174052.2073	parE.3003316.NC_007779.3172159_3174052.2073	1	1	539	992	parE_1	1893	1893	97.52	parE_1.l6.c30.ctg.1	2318	22.8	0	.	p	.	0	D473N	NONSYN	1417	1419	GAC	1671	1673	AAC	25;26;27	A;A;C	25;26;27	.	Escherichia coli parE conferring resistance to fluoroquinolones
parE.3003316.NC_007779.3172159_3174052.2073	parE.3003316.NC_007779.3172159_3174052.2073	1	1	539	992	parE_1	1893	1893	97.52	parE_1.l6.c30.ctg.1	2318	22.8	1	SNP	p	D476N	0	.	.	1426	1428	GAT	1680	1682	GAT	31;30;29	G;A;T	31;30;28	parE.3003316.NC_007779.3172159_3174052.2073:1:1:D476N:.:Point mutation in Escherichia coli parE resulting in fluoroquinolones resistance	Escherichia coli parE conferring resistance to fluoroquinolones
patA.3000024.NC_000913.3.3219493_3220873.3692	patA.3000024.NC_000913.3.3219493_3220873.3692	1	0	539	894	patA	1380	1380	99.78	patA.l15.c30.ctg.1	1799	26.5	0	.	p	.	0	P202Q	NONSYN	604	606	CCG	819	821	CAG	29;31;31	C;A;G	29;30;30	.	patA;PatA is an ABC transporter of Streptococcus pneumoniae that interacts with PatB to confer fluoroquinolone resistance.
patA.3000024.NC_000913.3.3219493_3220873.3692	patA.3000024.NC_000913.3.3219493_3220873.3692	1	0	539	894	patA	1380	1380	99.78	patA.l15.c30.ctg.1	1799	26.5	0	.	p	.	0	E360D	NONSYN	1078	1080	GAG	1293	1295	GAT	29;28;28	G;A;T	29;28;28	.	patA;PatA is an ABC transporter of Streptococcus pneumoniae that interacts with PatB to confer fluoroquinolone resistance.
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	2702	rpoB	4029	4029	99.03	rpoB.l15.c30.ctg.1	4486	32.3	1	SNP	p	V146F	0	.	.	436	438	GTT	665	667	GTT	31;31;31	G;T;T	30;31;31	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:V146F:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	2702	rpoB	4029	4029	99.03	rpoB.l15.c30.ctg.1	4486	32.3	1	SNP	p	Q513L	0	.	.	1537	1539	CAG	1766	1768	CAG	31;31;32	C;A;G	31;31;32	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:Q513L:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	2702	rpoB	4029	4029	99.03	rpoB.l15.c30.ctg.1	4486	32.3	1	SNP	p	Q513P	0	.	.	1537	1539	CAG	1766	1768	CAG	31;31;32	C;A;G	31;31;32	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:Q513P:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	2702	rpoB	4029	4029	99.03	rpoB.l15.c30.ctg.1	4486	32.3	1	SNP	p	H526Y	0	.	.	1576	1578	CAC	1805	1807	CAC	31;30;30	C;A;C	31;30;30	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:H526Y:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	2702	rpoB	4029	4029	99.03	rpoB.l15.c30.ctg.1	4486	32.3	1	SNP	p	R529S	0	.	.	1585	1587	CGT	1814	1816	CGT	30;29;30	C;G;T	30;29;30	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:R529S:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	2702	rpoB	4029	4029	99.03	rpoB.l15.c30.ctg.1	4486	32.3	1	SNP	p	R529C	0	.	.	1585	1587	CGT	1814	1816	CGT	30;29;30	C;G;T	30;29;30	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:R529C:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	2702	rpoB	4029	4029	99.03	rpoB.l15.c30.ctg.1	4486	32.3	1	SNP	p	S531F	0	.	.	1591	1593	TCC	1820	1822	TCC	30;30;29	T;C;C	29;30;29	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:S531F:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	2702	rpoB	4029	4029	99.03	rpoB.l15.c30.ctg.1	4486	32.3	1	SNP	p	L533P	0	.	.	1597	1599	CTC	1826	1828	CTC	26;25;24	C;T;C	26;25;23	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:L533P:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	2702	rpoB	4029	4029	99.03	rpoB.l15.c30.ctg.1	4486	32.3	1	SNP	p	T563P	0	.	.	1687	1689	ACC	1916	1918	ACC	34;35;36	A;C;C	34;35;36	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:T563P:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	2702	rpoB	4029	4029	99.03	rpoB.l15.c30.ctg.1	4486	32.3	1	SNP	p	P564L	0	.	.	1690	1692	CCT	1919	1921	CCT	37;37;37	C;C;T	37;37;37	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:P564L:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	2702	rpoB	4029	4029	99.03	rpoB.l15.c30.ctg.1	4486	32.3	1	SNP	p	R687H	0	.	.	2059	2061	CGT	2288	2290	CGT	44;44;43	C;G;T	44;44;43	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:R687H:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rrsH.3003372.U00096.223771_225312.3228	rrsH.3003372.U00096.223771_225312.3228	0	0	691	7152	rrsB+	1542	1542	99.61	rrsB+.l15.c17.ctg.1	1724	209.5	0	.	n	.	0	A80C	SNP	80	80	A	248	248	C	214	C	211	.	Escherichia coli 16S rRNA mutation in the rrsH gene conferring resistance to spectinomycin
rrsH.3003372.U00096.223771_225312.3228	rrsH.3003372.U00096.223771_225312.3228	0	0	691	7152	rrsB+	1542	1542	99.61	rrsB+.l15.c17.ctg.1	1724	209.5	0	.	n	.	0	C90T	SNP	90	90	C	258	258	T	222	T,C	163,57	.	Escherichia coli 16S rRNA mutation in the rrsH gene conferring resistance to spectinomycin
rrsH.3003372.U00096.223771_225312.3228	rrsH.3003372.U00096.223771_225312.3228	0	0	691	7152	rrsB+	1542	1542	99.61	rrsB+.l15.c17.ctg.1	1724	209.5	0	.	n	.	0	T93C	SNP	93	93	T	261	261	C	229	C	228	.	Escherichia coli 16S rRNA mutation in the rrsH gene conferring resistance to spectinomycin
rrsH.3003372.U00096.223771_225312.3228	rrsH.3003372.U00096.223771_225312.3228	0	0	691	7152	rrsB+	1542	1542	99.61	rrsB+.l15.c17.ctg.1	1724	209.5	0	.	n	.	0	T1120C	SNP	1120	1120	T	1288	1288	C	233	C	233	.	Escherichia coli 16S rRNA mutation in the rrsH gene conferring resistance to spectinomycin
rrsH.3003372.U00096.223771_225312.3228	rrsH.3003372.U00096.223771_225312.3228	0	0	691	7152	rrsB+	1542	1542	99.61	rrsB+.l15.c17.ctg.1	1724	209.5	1	SNP	n	C1192T	0	.	.	1192	1192	C	1360	1360	C	273	C	271	rrsH.3003372.U00096.223771_225312.3228:0:0:C1192T:.:Point mutations in the 3' major domain of the rrsH 16S rRNA gene of Escherichia coli can confer resistance to spectinomycin	Escherichia coli 16S rRNA mutation in the rrsH gene conferring resistance to spectinomycin
rrsH.3003372.U00096.223771_225312.3228	rrsH.3003372.U00096.223771_225312.3228	0	0	691	7152	rrsB+	1542	1542	99.61	rrsB+.l15.c17.ctg.1	1724	209.5	0	HET	.	.	.	A250T	.	250	250	A	418	418	A	230	A,T	177,52	.	Escherichia coli 16S rRNA mutation in the rrsH gene conferring resistance to spectinomycin
rrsH.3003372.U00096.223771_225312.3228	rrsH.3003372.U00096.223771_225312.3228	0	0	691	7152	rrsB+	1542	1542	99.61	rrsB+.l15.c17.ctg.1	1724	209.5	0	HET	.	.	.	G474A	.	474	474	G	642	642	G	232	G,A	176,55	.	Escherichia coli 16S rRNA mutation in the rrsH gene conferring resistance to spectinomycin
rrsH.3003372.U00096.223771_225312.3228	rrsH.3003372.U00096.223771_225312.3228	0	0	691	7152	rrsB+	1542	1542	99.61	rrsB+.l15.c17.ctg.1	1724	209.5	0	HET	.	.	.	A253T	.	253	253	A	421	421	A	228	A,T	176,51	.	Escherichia coli 16S rRNA mutation in the rrsH gene conferring resistance to spectinomycin
rrsH.3003372.U00096.223771_225312.3228	rrsH.3003372.U00096.223771_225312.3228	0	0	691	7152	rrsB+	1542	1542	99.61	rrsB+.l15.c17.ctg.1	1724	209.5	0	HET	.	.	.	C194T	.	194	194	C	362	362	C	161	C,T	131,29	.	Escherichia coli 16S rRNA mutation in the rrsH gene conferring resistance to spectinomycin
rrsH.3003372.U00096.223771_225312.3228	rrsH.3003372.U00096.223771_225312.3228	0	0	691	7152	rrsB+	1542	1542	99.61	rrsB+.l15.c17.ctg.1	1724	209.5	0	HET	.	.	.	A1002G	.	1002	1002	A	1170	1170	A	200	A,G	99,96	.	Escherichia coli 16S rRNA mutation in the rrsH gene conferring resistance to spectinomycin
rrsH.3003372.U00096.223771_225312.3228	rrsH.3003372.U00096.223771_225312.3228	0	0	691	7152	rrsB+	1542	1542	99.61	rrsB+.l15.c17.ctg.1	1724	209.5	0	HET	.	.	.	C1006G	.	1006	1006	C	1174	1174	C	201	C,G	103,93	.	Escherichia coli 16S rRNA mutation in the rrsH gene conferring resistance to spectinomycin
rrsH.3003372.U00096.223771_225312.3228	rrsH.3003372.U00096.223771_225312.3228	0	0	691	7152	rrsB+	1542	1542	99.61	rrsB+.l15.c17.ctg.1	1724	209.5	0	HET	.	.	.	A79G	.	79	79	G	247	247	A	211	A,G	156,53	.	Escherichia coli 16S rRNA mutation in the rrsH gene conferring resistance to spectinomycin
rrsH.3003372.U00096.223771_225312.3228	rrsH.3003372.U00096.223771_225312.3228	0	0	691	7152	rrsB+	1542	1542	99.61	rrsB+.l15.c17.ctg.1	1724	209.5	0	HET	.	.	.	C719T	.	719	719	C	887	887	C	199	C,T	120,78	.	Escherichia coli 16S rRNA mutation in the rrsH gene conferring resistance to spectinomycin
rrsH.3003372.U00096.223771_225312.3228	rrsH.3003372.U00096.223771_225312.3228	0	0	691	7152	rrsB+	1542	1542	99.61	rrsB+.l15.c17.ctg.1	1724	209.5	0	HET	.	.	.	T273A	.	273	273	T	441	441	T	235	T,A	176,58	.	Escherichia coli 16S rRNA mutation in the rrsH gene conferring resistance to spectinomycin
rrsH.3003372.U00096.223771_225312.3228	rrsH.3003372.U00096.223771_225312.3228	0	0	691	7152	rrsB+	1542	1542	99.61	rrsB+.l15.c17.ctg.1	1724	209.5	0	HET	.	.	.	C1010T	.	1010	1010	C	1178	1178	C	199	C,T	106,92	.	Escherichia coli 16S rRNA mutation in the rrsH gene conferring resistance to spectinomycin
rrsH.3003372.U00096.223771_225312.3228	rrsH.3003372.U00096.223771_225312.3228	0	0	691	7152	rrsB+	1542	1542	99.61	rrsB+.l15.c17.ctg.1	1724	209.5	0	HET	.	.	.	T1038C	.	1038	1038	T	1206	1206	T	193	T,C	106,86	.	Escherichia coli 16S rRNA mutation in the rrsH gene conferring resistance to spectinomycin
rrsH.3003372.U00096.223771_225312.3228	rrsH.3003372.U00096.223771_225312.3228	0	0	691	7152	rrsB+	1542	1542	99.61	rrsB+.l15.c17.ctg.1	1724	209.5	0	HET	.	.	.	C183T	.	183	183	C	351	351	C	156	C,T	109,46	.	Escherichia coli 16S rRNA mutation in the rrsH gene conferring resistance to spectinomycin
sat_1.3002895.AB211124.0_525.584	sat_1.3002895.AB211124.0_525.584	1	0	27	360	sat_1	525	525	100.0	sat_1.l15.c4.ctg.1	1004	19.3	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	sat-1;sat-1 is a plasmid-mediated streptothricin acetyltransferase in Escherichia coli
soxR.3003381.U00096.4277468_4277933.2074	soxR.3003381.U00096.4277468_4277933.2074	1	1	27	344	soxR	465	465	100.0	soxR.l6.c4.ctg.1	826	22.1	1	SNP	p	R20H	0	.	.	58	60	CGC	222	224	CGC	27;28;28	C;G;C	27;28;28	soxR.3003381.U00096.4277468_4277933.2074:1:1:R20H:.:SoxR is a sensory protein that upregulates soxS expression in the presence of redox-cycling drugs. This stress response leads to the expression many multidrug efflux pumps.	Escherichia coli soxR mutants
soxR.3003381.U00096.4277468_4277933.2074	soxR.3003381.U00096.4277468_4277933.2074	1	1	27	344	soxR	465	465	100.0	soxR.l6.c4.ctg.1	826	22.1	1	SNP	p	G121D	0	.	.	361	363	GGT	525	527	GGT	25;25;25	G;G;T	25;25;25	soxR.3003381.U00096.4277468_4277933.2074:1:1:G121D:.:SoxR is a sensory protein that upregulates soxS expression in the presence of redox-cycling drugs. This stress response leads to the expression many multidrug efflux pumps.	Escherichia coli soxR mutants
soxS.3003511.NC_000913.4277059_4277383.3528	soxS.3003511.NC_000913.4277059_4277383.3528	1	1	27	246	soxS_1	324	324	99.69	soxS_1.l6.c17.ctg.1	717	18.3	1	SNP	p	A12S	0	.	.	34	36	GCA	222	224	GCA	24;25;25	G;C;A	24;25;25	soxS.3003511.NC_000913.4277059_4277383.3528:1:1:A12S:.:SoxS is a global regulator that up-regulates the expression of AcrAB efflux genes. It also reduces OmpF expression to decrease cell membrane permeability.	Escherichia coli soxS mutant
tolC.3000237.FJ768952.0_1488.563	tolC.3000237.FJ768952.0_1488.563	1	0	27	1028	tolC	1488	1488	98.72	tolC.l6.c4.ctg.1	1892	29.1	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	tolC;TolC is a protein subunit of many multidrug efflux complexes in Gram negative bacteria. It is an outer membrane efflux protein and is constitutively open. Regulation of efflux activity is often at its periplasmic entrance by other components of the efflux complex.
